Components including protective sheaths for inserting medical objects into soft tissue.
By designing a water-resistant sleeve, the device can be controlled to break under axial or radial forces at its weak points, thus solving the problem of protecting delicate medical objects when inserted into soft tissue. This reduces tissue damage and material diffusion, ensuring the device can operate quickly after positioning.
Patent Information
- Application Number
- CN202580028974.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-18
- Filing Date
- 2025-04-18
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies struggle to effectively protect delicate and flexible medical objects during insertion into soft tissue, prevent premature contact with bodily fluids, reduce tissue damage, ensure rapid device operation after positioning, and prevent unintended material diffusion and tissue rupture during insertion.
A water-resistant sleeve is used, which has a weak section at the distal end that can be broken in a controlled manner by axial or radial force. This protects the slender device from the influence of tissues and body fluids during insertion and exposes the device after positioning. The sleeve material is a polymer such as parylene, with a thickness of less than 100 µm, and is coated with a friction reducer to reduce friction.
It achieves effective protection of medical objects during insertion into soft tissue, reduces tissue damage, ensures the device works rapidly after positioning, avoids material diffusion and tissue rupture, and provides time-controlled waterproof protection.
Smart Images

Figure CN123125013A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a component configured for insertion into a medical object, the component including a water-resistant sleeve that accommodates an elongated device with a diameter of less than 5 mm, the sleeve including at least one weak portion that induces the expected breakage of the sleeve after the component is inserted into soft tissue, particularly nerve tissue. Background Technology
[0002] This invention relates to thin objects introduced into soft tissues such as neural and endocrine tissues. Some objects are very thin (between 1 µm and 150 µm in diameter) and therefore often very flexible, making insertion into soft tissue difficult or even impossible. Objects introduced into neural tissues such as brain tissue for stimulation and monitoring should ideally be flexible enough to accommodate the movement of the brain tissue, thereby minimizing tissue stimulation and thus providing conditions for proper operation over extended periods. Thin objects such as microelectrodes for stimulating and monitoring brain tissue should be fairly flexible to minimize tissue damage during insertion, but require a certain degree of structural support for introduction into the brain tissue. One way to provide structural support to thin objects such as microelectrodes for, for example, deep brain stimulation is to embed the object in a soluble matrix that provides stiffness when dry (WO 2008 / 091197, WO 2010 / 1441016). The matrix material must also be biocompatible and regulatory approved. Therefore, matrix materials that provide stiffness must dissolve / disintegrate and / or change their mechanical properties from rigid to flexible when subjected to soft tissue (soft tissue fluid). It has been proven challenging to calibrate matrix materials so that they provide sufficient stiffness during insertion and dissolve or change their mechanical properties promptly once positioned. The present invention's assembly, including a water-resistant, ruptureable sheath, mitigates many of the drawbacks of matrix materials that provide stiffness for thin and flexible elongated medical devices, such as microelectrodes.
[0003] Once the device is positioned in the tissue, it is preferable that the implanted device has a blunt and smooth profile to reduce tissue irritation and decrease the risk of puncturing nearby blood vessels due to soft tissue movement. Tissue movement is caused by heartbeat, respiration, and accelerated movement of body parts. Soft tissue movement can induce shearing between the implanted device and adjacent tissue, often triggering inflammatory processes (Köhler et al., PLOS ONE, 2015). Therefore, when residing in the tissue, the device should be able to follow tissue movement to reduce shear forces. As mentioned above, highly flexible elements such as microelectrodes can be inserted into soft tissue by embedding them in a rigid but soluble / degradable matrix material (WO 2019 / 03936). Soluble matrix materials for encapsulating drugs and implantable electrodes are known, such as gelatin and Kollicoat® (Etermadi et al., PLOS ONE, 2016). However, when such matrix-embedded devices are implanted, water may enter the structure immediately as the device penetrates the tissue, potentially softening the structure before full implantation and causing the device to deviate from the intended insertion path. This risk increases when the device is implanted deep in soft tissue, such as the brain, due to the longer insertion time. This challenge can be overcome by using a higher insertion speed, but higher speeds may increase the risk of tissue rupture. However, dissolution time can vary with factors such as body temperature, the water content of the tissue being penetrated, and the local pH. Therefore, the insertion speed required to avoid premature dissolution is difficult to predict accurately.
[0004] Another issue is that the performance of devices embedded in the substrate may be impaired by moisture or water contact before insertion.
[0005] Another challenge is ensuring the device is functional once correctly positioned. However, applying a matrix that dissolves / degrades more rapidly after positioning, enabling the electrodes to function quickly, increases the risk of loss of rigidity before reaching the target location or the risk of tissue damage due to rapid insertion. Therefore, for devices including components that dissolve / degrade in body fluids (or lipids) during insertion, a waterproof protection is needed that is independent of parameters such as body temperature, tissue water content, or local pH, and can be terminated / removed immediately in a time-controlled manner. As mentioned above, this waterproof protection also needs to have a shape that causes as little tissue damage as possible during insertion. With the components of this invention, a stiffening matrix having, for example, very rapid dissolution properties can be applied, which are rapidly triggered immediately after positioning by rupturing the cannula.
[0006] For devices containing materials whose physical properties change upon contact with soft tissue (such as materials that are soluble / degradable in body fluids or lipids), there is a corresponding need to provide time-controlled waterproofing protection. Such materials include, for example, gelling materials or materials that polymerize upon contact with body fluids, drugs or drug suspensions, or other materials such as biomarkers, materials that provide improved contrast in MRI or CT, liquid gels, living cells, or tissues.
[0007] It is also necessary to reduce the diffusion of material to unintended targets during insertion into soft tissue. Known solutions for injecting such materials into tissue include hollow, watertight catheters with an opening at the tip, such as injection needles. Due to this opening, some material may leak out during insertion, leading to unintended side effects.
[0008] It is also important to minimize tissue damage during insertion. During insertion into soft tissue (such as brain or neuroendocrine tissue), the probe will displace or partially penetrate the tissue, thereby damaging the tissue along that path. Compression or denudation of the tissue can occur when the probe is too blunt to prevent lateral sliding of the tissue during insertion, or if the tissue to be implanted is tough or elastic (such as the fibrous tissue of the arachnoid mater covering the brain / spinal cord, or other parts of the meninges, i.e., the dura mater and pia mater). Insertion pressure is known to cause severe hypoxia in the tissue to be implanted, which, if prolonged, can damage neural tissue (Kumosa and Schouenborg, 2021). Therefore, the tip of the probe generally needs to be relatively sharp to reduce surface indentation, which can lead to increased mechanical stress on the tissue. On the other hand, an overly sharp tip may puncture a blood vessel during probe insertion, causing bleeding, which can induce a tissue reaction. Unless the probe is intended to be inserted into a blood vessel, such as during cannulation for infusion or blood sampling, a tissue reaction induced by bleeding can impair the function of the implanted probe. Using this component, the shape of the distal segment and distal end can be optimized for specific types of soft tissue and / or insertion purposes to facilitate insertion.
[0009] Another problem is that the distal opening of the injection needle may be damaged along the insertion path due to the cutting action of the thin wall at the tip of the needle, and tissue debris may contaminate the material to be discharged from the injection needle.
[0010] Another issue involves biopsies when collecting tissue samples or tissue fragments from a specific tissue. In such cases, contamination of the biopsy sample from tissue traversed during probe insertion should be avoided as much as possible.
[0011] Another issue concerns vascular cannulation used for infusions or blood sampling. In cases of fragile vessels (common in the elderly), the process of inserting a cannula with a sharp, cutting tip into a vessel can easily lead to unintended bleeding due to excessive vessel rupture. Therefore, it is desirable to reduce the risk of unintended vessel wall rupture during the insertion of the probe. Another issue concerns the implantation of live cells or aggregates thereof into soft tissue. Known methods of cell implantation involve using a syringe and, after placing the syringe in the target tissue, injecting the cells into the target tissue. One problem with known methods is that the injection volume causes tissue expansion, which can lead to tissue rupture. To reduce tissue rupture at the injection site, injection should therefore be performed slowly. However, in the case of injecting live cells, slow injection may pose a risk of killing or damaging the cells due to the gradual development of hypoxia and / or hypoxia within the injection cannula.
[0012] Another issue in implanting live cells or aggregates thereof involves the need to optimize the environment to enhance the survival rate of the inserted cells. Introducing cells into an environment where an acute tissue response has already been triggered by damage from the insertion process can be problematic. The proliferation of live cells in host tissue can also be enhanced by electrical stimulation, for example, by providing electrical stimulation to the delivery volume of live cells via a probe. The present invention provides the means for providing a device for delivering live cells or cell aggregates, which further includes tools for stimulating the live cells, the device being surrounded by a cannula of the present invention.
[0013] The present invention aims to solve or at least mitigate the problems presented herein by means of an arrangement for inserting a medical object into a target site in soft tissue and preparing it to perform its intended function. Purpose of the invention
[0014] One objective is to provide waterproof protection for implantable devices containing materials that may dissolve, degrade, or otherwise be affected by contact with bodily fluids or tissue during insertion into soft tissue, wherein the waterproof protection can be terminated in a controlled manner by an operator (e.g., a surgeon or robot).
[0015] Another objective is to provide an arrangement that improves the timing of contact between bodily fluids and the medical object after insertion into soft tissue.
[0016] Another objective is to provide an arrangement that provides waterproof protection for implantable devices, reducing tissue damage caused by insertion.
[0017] Another objective is to provide an arrangement for implanting electrodes, materials polymerized in situ into conductive materials, drugs, electronic chips, optical waveguides, cells or tissues, or any combination of such medical objects into soft tissues such as the nervous system, muscles, and endocrine organs.
[0018] Another objective is to provide an arrangement that enables controlled delivery of therapeutic agents (such as drugs or cells) in space and time, without the need for conventional injections via needles, thereby reducing the risk of tearing of the target tissue caused by injection.
[0019] Another objective is to provide a component having a shape that reduces tissue rupture during insertion into a blood vessel, and which can be converted into a catheter with a distal opening after insertion.
[0020] Another objective is to facilitate or enable the insertion of elongated devices with complex shapes and / or high-friction surfaces into soft tissue.
[0021] Another objective is to improve the proliferation of live cells and live cell aggregates in soft host tissues.
[0022] Another objective is to deliver live cells and live cell aggregates to a target volume within soft tissue while minimizing the pressure used for delivery, or even eliminating the need for pressure during delivery, and preferably reducing cell transfer time.
[0023] Other purposes are obvious from the description herein. General description of the invention
[0024] This invention is based on the understanding that a water-resistant polymer protective sheath with a structurally weak point allows for controlled rupture of the sheath. Controlled rupture of the sheath, particularly in the distal segment, can be induced by applying axial and / or radial forces from within the sheath. Radial forces on the water-resistant sheath can be generated through expansion. Axial forces on the distal segment of the water-resistant sheath are preferably induced by an elongated device housed within the sheath. Therefore, an assembly including the sheath according to the invention can be used to protect a medical object from premature contact with soft tissue during insertion and to allow controlled exposure of the object to the target soft tissue upon sheath removal. In other words, the sheath-integrated assembly of the invention protects the medical object from premature contact with tissue and bodily fluids during soft tissue insertion until the sheath ruptures in a controlled manner and is removed. Provided the overall tensile strength of the sheath is higher than that of the weak point, the weak point will rupture before the rest of the sheath when a sufficiently strong force is applied to the sheath.
[0025] This invention is also based on the understanding that by adding a sleeve to an elongated device, the distal shape of the device can be temporarily masked, thereby reducing tissue damage during insertion, while retaining the distal shape designed to minimize damage once correctly positioned. If the sleeve provides a friction-reducing shape and surface, it can also provide protection to soft tissue during the insertion procedure. Therefore, the surface of the protective sleeve can be smooth, slippery, and / or coated with a material that reduces friction with soft tissue to minimize tissue damage during insertion. Thus, this invention enables the insertion of elongated devices that would otherwise be unsuitable for insertion into soft tissue due to, for example, complex shapes and / or high-friction surfaces.
[0026] The present invention is further based on the understanding that the removable protective sleeve can be equipped with means for monitoring the insertion procedure itself and the integrity of the protective sleeve during the insertion procedure.
[0027] In general, the present invention relates to an assembly configured for insertion into a medical object, the assembly comprising a water-resistant sleeve accommodating an elongated device having a diameter of less than 5 mm, the elongated device including at least one elongated rigid element, the assembly preferably being suitable for implantation in soft tissue. In some embodiments, the medical object, the elongated device, and the elongated rigid element may be the same entity, such as a microelectrode embedded in a matrix providing structural rigidity (stiffness). The assembly must have the stiffness to allow the device to be inserted into soft tissue as required by the specific application. If the elongated device comprises two or more objects, one of which is a medical object, it may be necessary to have only one object providing sufficient stiffness for the elongated medical device.
[0028] The elongated device may comprise one or more objects / elements and at least one medical object. The medical object needs to: a) be protected from the effects of tissue or bodily fluids during insertion into soft tissue, b) require structural support during insertion due to its high mechanical flexibility, and / or c) be precisely administered into the target tissue during insertion. Examples of such medical objects are: 1) objects comprising materials that are soluble, degradable, or otherwise affected upon contact with bodily fluids or tissue; 2) electrodes and multichannel electrodes, electronic devices, optical fibers, or other types of filaments such as microcatheters; and 3) drugs, cells, and other bioactive agents / materials.
[0029] A specific feature of this invention is the very thin wall of the sleeve. Therefore, the sleeve wall preferably has an average thickness of less than 100 µm, more preferably less than 50 µm, for example from 0.2 µm to 50 µm. For some applications, the sleeve wall thickness may be greater than 100 µm. The sleeve comprises a water-resistant polymer material, or comprises multiple polymer materials that together form the water-resistant sleeve. The water-resistant sleeve at least partially surrounds the elongated device during insertion into soft tissue, wherein the sleeve has a structurally weak portion. After the sleeve accommodating the elongated device is properly positioned, the sleeve is ruptured by applying an axial force and / or a radial force. The axial force on the sleeve, particularly at the distal end of the sleeve, can preferably be provided by moving the distal segment of the sleeve in a proximal direction while preferably keeping the elongated device stationary. Another option for rupturing the sleeve is by dilation, for example by increasing the pressure inside the sleeve to cause the sleeve to rupture in the region with the structurally weak portion.
[0030] The cannula also includes at least one withdrawal aid and / or positioning element integrated or attached to the proximal segment of the cannula. The withdrawal aid may consist of one or more thin drawstrings integrated or attached to the proximal segment of the cannula. Once positioned, the drawstrings are preferably arranged proximally from the cannula so that an operator or specialized device can remove the cannula from the soft tissue by pulling the drawstrings to move the distal segment of the cannula proximally.
[0031] The sleeve may also be coated with a friction-reducing agent. The sleeve may also include one or more sensors, or electrodes connected to electronics, to provide information about, for example, premature failure of waterproofing protection.
[0032] Furthermore, the present invention also covers a method for inserting an elongated medical device comprising at least one elongated rigid structural element into soft tissue, and a method for manufacturing an assembly.
[0033] Other aspects and implementation methods will be disclosed and described herein.
[0034] definition
[0035] The following terms are used to describe aspects and embodiments of the present invention in a general sense.
[0036] The terms "distal" and "proximal" are used to refer to segments, regions, or portions (or any other equivalent terms) of elongated / slender entities such as elongated medical devices, cannulas, elements, and objects. Distal refers to a portion, segment, region, etc., located deeper within soft tissue than a proximal segment or region. A distal segment extends from the distal end in a proximal direction. A proximal segment extends from the proximal end in a distal direction. The terms "distal" and "proximal" are not absolute in location, but rather relative.
[0037] The distal end of the casing is defined as the farthest part of the casing.
[0038] The term "distal end region" defines the portion of the sleeve in the distal segment where the diameter begins to taper toward the distal end, including the distal end.
[0039] The distal segment includes the distal end region and the distal end.
[0040] In this context, a "medical object" is an object that interacts with a human or animal body after insertion into human tissue, such as to perform diagnostic, therapeutic, or in any way to facilitate the collection of information about the condition of the human or animal body. In the context of this invention, the medical object requires protection by a protective sheath, at least during insertion into soft tissue. The medical object can also be an object requiring a short transfer time, such as living cells or cell aggregates. The medical object may be selected from medical devices that monitor and / or stimulate soft tissue by, for example, electrical, thermal, ultrasonic, optogenetic, or mechanical monitoring and / or stimulation; and from compounds, peptides, proteins, biological macromolecules, and microorganisms, such as drugs, peptides, proteins, genes, living cells, and living cell aggregates.
[0041] The term "elongated" characterizes a solid entity that typically has a length significantly greater than its radial extension by an axial extension. Elongated solids can have aspect ratios greater than 10:1, 20:1, 30:1, or 50:1. Typically, elongated devices have a width and diameter less than 5 mm and a length less than 15 cm, 10 cm, or 5 cm, respectively. Elongated solids (such as devices, elements, objects, microelectrodes, and other medical objects / elements) typically have a proximal segment and a distal segment, wherein the distal portion includes a distal end configured to support insertion into soft tissue. The assembly includes a protective sheath that protectively surrounds the elongated device. In embodiments, the elongated device may further include elements that provide structural support during insertion into soft tissue, i.e., elongated rigid elements.
[0042] The "elongated device" can be the medical object itself. Alternatively, the elongated device includes at least one medical object. If the elongated device itself does not provide sufficient structural rigidity to allow the component to be inserted into soft tissue, then the elongated device must include at least one element that imparts rigidity. The elongated device preferably has sufficient structural rigidity (stiffness) to allow weak areas of the cannula (such as scoring lines, breakable lines, tear lines, exemplified by slits / grooves / dents) to break.
[0043] The "rigidifying element" can be the elongated device itself. Alternatively, the elongated device may include at least one rigidifying element. The rigidifying element can be a material that provides structural rigidity to the elongated device, such as a water-soluble, biodegradable matrix material that is rigid when dry. Alternatively, the rigidifying element is an elongated rigid element, such as a pin or a hollow structure.
[0044] The component includes an elongated device and a water-resistant sleeve configured for insertion into a medical object. The component as a whole needs to be sufficiently rigid for insertion into soft tissue and preferably follows a controlled trajectory to reach a predetermined location within the soft tissue.
[0045] "Sleeve" or "protective sleeve" refers to an elongated tubular element that surrounds (encloses) at least the distal section of an elongated device. The sleeve includes at least one weak point, preferably in the form of a longitudinally scored / fractured / tearable zone. This weak point can be achieved by mechanical, thermal, structural, dimensional, or chemical weaknesses of the sleeve. This weak point allows the sleeve to fracture in a controlled manner. The sleeve can have any length, but its length is preferably no longer than the elongated device.
[0046] "Water-resistant polymeric materials" refer to materials that substantially prevent tissue fluid from reaching the interior of the cannula, at least before intentionally causing it to rupture. Minor fluid leakage is tolerable if the overall rigidity of the elongated device (or rigid element) is not compromised. For some applications, it is preferable that the cannula material be waterproof, meaning it is impermeable to water. Waterproof cannula materials can be advantageous if a soluble and / or degradable matrix is used to impart rigidity. For applications where the elongated device has inherent rigidity, i.e., its rigidity does not decrease upon exposure to water, water-resistant cannula materials may be sufficient. Polymer cannula materials can also be flexible to some extent. Preferred polymeric cannula materials are parylene-based polymers, such as parylene N, parylene C, parylene D, and parylene HT. Parylene is relatively rigid compared to flexible elastomers such as soft polyurethane PDMS. The polymer sheath material may have an elongation at break of at least 10%, such as from about 10% to about 250%, such as from about 25% to about 100%.
[0047] The casing can be water-resistant, waterproof, or non-aqueous degradable. Water-resistant or non-aqueous degradable means that the casing is completely resistant to degradation, dissolution, or structural damage when exposed to water or aqueous environments, especially soft tissue and soft tissue fluids. Preferably, the casing maintains its mechanical integrity, chemical stability, and functional properties over time in the presence of moisture or biological fluids.
[0048] The “distal section” of a casing is defined as the distal portion of the casing that narrows in the radial dimension.
[0049] The term "constructed for insertion into soft tissue" means that the components and corresponding protective sheaths are of a suitable shape to penetrate soft tissue without causing unnecessary irritation and to reduce the risk of puncturing blood vessels.
[0050] Removal aids and / or positioning elements are integrated or attached to the proximal segment of the cannula. Removal aids may be pull wires or flanges that are attached, adhered to, or integrated into the proximal segment of the cannula. Flanges have radial extensions. In addition to facilitating cannula removal from soft tissue, flanges can also be used to position the assembly axially.
[0051] The statement that the protective sleeve is "removable as a whole" means that after insertion and rupture of the fracturing seal, the protective sleeve should be able to be removed entirely without leaving any loose fragments or other debris in the soft tissue.
[0052] The term "temporarily and / or permanently rigid components" in an elongated device means that the elongated device itself, or in combination with elements that impart rigidity, provides sufficient structural support to aid insertion and, in embodiments of the invention, sufficient rigidity to aid in the mechanical breaking of a breakable seal. Temporary rigidity means that it is rigid only temporarily until it dissolves or softens upon contact with bodily fluids.
[0053] The term "connectable to a guiding system" describes a medical object or its accessory that is arranged to directly or indirectly assist in achieving the displacement of the elongated device required when inserting it into soft tissue, and / or the controlled displacement when causing the protective sheath to rupture.
[0054] The term "transfer time" refers to the time it takes to transfer a medical object (such as a suspension containing live cells) from an external source to a target site in soft tissue.
[0055] The term "microelectrode" is defined herein as an insulated conductive lead (conductive core), preferably having a diameter of less than 100 µm, less than 75 µm, or less than 50 µm, and having at least one non-insulated segment. The lead may be made of any material, such as metal or conductive polymer.
[0056] A multichannel microelectrode is a body containing multiple electrically insulated leads, each lead having one or more non-insulated active sites.
[0057] "Soft tissue" is broadly defined as any type of soft tissue, including supporting tissue, connective tissue, nervous tissue, endocrine tissue, muscle tissue, vascular and lymphatic tissue, epithelial tissue, retinal tissue, and hematopoietic and immune tissue. Nervous tissue can be divided by functional regions, including the central nervous system (CNS), the brain (including the cerebral cortex, deep white matter nuclei, cerebellum, and brainstem); the spinal cord (including the central canal, anterior and posterior horns, and ascending and descending tracts); the peripheral nervous system (PNS), including cranial nerves and spinal nerves; and ganglia, such as dorsal root ganglia and autonomic ganglia. Nervous tissue can also be characterized by cellular components, including excitable cells such as cell bodies, dendrites (input), and axons (output); and glial cells such as astrocytes, oligodendrocytes, microglia, ependymal cells, Schwann cells, and satellite cells. Soft tissue excludes hard tissue, such as bone. Soft tissue can be derived from nervous tissue, endocrine tissue, muscle tissue, connective tissue, and retinal tissue. Soft tissue encompasses any soft tissue that provides a detectable electrical fingerprint and / or any tissue susceptible to electrical stimulation. The term soft tissue also includes hollow fluid spaces, such as ventricles of the brain.
[0058] "Flexible" medical objects or cannulas are defined as medical objects or cannulas that require structural support to be pushed through soft tissues (such as the brain) without significant bending.
[0059] "Injection-free placement" of an object is defined as when the object enters the tissue without applying pressure to the tissue, or with only minimal pressure. Summary of the Invention
[0060] This invention is defined by the terminology of the claims. The invention is also defined by any conceivable combination of the features presented herein. Any conceivable combination of features will be apparent to those skilled in the art and should not be considered as constituting new knowledge.
[0061] The present invention relates to an assembly configured for inserting a medical object requiring protection into soft tissue such as nerve tissue, the assembly comprising a water-resistant sleeve that houses (encloses) an elongated device; an assembly comprising an elongated device housed (enclosed) by a water-resistant sleeve; an elongated device housed (enclosed) by a water-resistant sleeve; the water-resistant sleeve itself; a method for inserting the elongated device housed in the water-resistant sleeve; and a method for manufacturing an assembly comprising the elongated device.
[0062] To cover all aspects of the invention in relation to the product, one aspect of the invention relates to the components described in the preceding paragraph, the elongated device surrounded (enclosed) by a water-resistant sleeve, and the water-resistant sleeve that encloses (encloses) the elongated device. The latter aspect emphasizes the water-resistant sleeve more than the elongated device in its wording. While both the elongated device and the water-resistant sleeve are important features of the inventive concept, the water-resistant sleeve possesses specific characteristics disclosed herein that are fundamental to the proper functioning of the concept. More specifically, one aspect of the invention relates to an assembly configured for inserting a medical object requiring protection into soft tissue, such as nerve tissue. The assembly includes a water-resistant sheath housing an elongated device comprising at least one rigid element, the elongated device having an overall diameter of less than about 5 mm, preferably less than 2 mm. The sheath has a proximal segment and a distal segment, and a distal end, the proximal segment extending distally from the proximal end, the distal segment extending proximally from the distal end, the diameter of the distal segment gradually decreasing toward the distal end. The sheath includes a sheath wall comprising a water-resistant polymer material having a diameter of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm. The sleeve has an average thickness of µm to 50 µm; the sleeve further includes at least one withdrawal aid and / or positioning element integrated or attached to the proximal segment of the sleeve; wherein the sleeve (or sleeve wall) includes a weak portion at least in the distal segment, the weak portion enabling the distal segment of the sleeve to rupture by axial and / or radial forces (when axial and / or radial forces are applied).
[0063] Another aspect of the invention relates to an assembly configured for inserting a medical object requiring protection into soft tissue, such as nerve tissue, the assembly comprising a water-resistant sheath accommodating an elongated device having an average diameter of less than about 5 mm, preferably less than 2 mm; the sheath having a proximal segment and a distal segment and a distal end, the proximal segment extending from the proximal end in a distal direction, the distal segment extending from the distal end in a proximal direction, the diameter of the distal segment gradually decreasing toward the distal end; the sheath comprising a sheath wall comprising a water-resistant polymer material having an average thickness of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm; the sheath further comprising at least one drawwire integrated or attached to the proximal segment of the sheath; the sheath (sheath wall) including a weak portion at least in the distal segment, the weak portion enabling the distal segment to rupture (break) when an axial force is applied by the elongated medical device to the distal segment, such as the distal end region, preferably the distal end.
[0064] Another aspect of the invention relates to a water-resistant sleeve housing an elongated device, preferably configured for insertion into soft tissue such as nerve tissue, the elongated device having an overall diameter of less than about 5 mm, preferably less than 2 mm; the water-resistant sleeve having a proximal segment and a distal segment and a distal end, the proximal segment extending from the proximal end toward the distal end, the distal segment extending from the distal end toward the proximal end, the diameter of the distal segment gradually decreasing toward the distal end; the sleeve includes a sleeve wall comprising a water-resistant polymer material, the sleeve wall having an average thickness of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm; the sleeve further includes at least one withdrawal aid and / or positioning element integrated or attached to the proximal segment of the sleeve, wherein the sleeve (or sleeve wall) includes a weak portion at least in the distal segment, the weak portion being capable of breaking the distal segment of the sleeve by axial and / or radial forces (when axial and / or radial forces are applied).
[0065] Another aspect of the invention relates to an elongated device configured for insertion into soft tissue such as nerve tissue, the elongated device having an overall diameter of less than about 5 mm, preferably less than 2 mm, the elongated device being received (enclosed) by a water-resistant sleeve; the water-resistant sleeve having a proximal segment and a distal segment and a distal end, the proximal segment extending from the proximal end toward the distal end, the distal segment extending from the distal end toward the proximal end, the diameter of the distal segment gradually decreasing toward the distal end; the sleeve includes a sleeve wall comprising a water-resistant polymer material, the sleeve wall having an average thickness of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm; the sleeve further includes at least one withdrawal aid and / or positioning element integrated or attached to the proximal segment of the sleeve, wherein the sleeve (or sleeve wall) includes a weak portion at least in the distal segment, the weak portion being capable of breaking the distal segment of the sleeve by axial and / or radial forces (when axial and / or radial forces are applied).
[0066] An additional aspect of the invention relates to a method of inserting an elongated device comprising at least one rigid element into soft tissue, such as nerve tissue, the elongated medical device having an overall diameter of less than about 5 mm, preferably less than 2 mm, the method comprising receiving at least a portion of the elongated device in a water-resistant sleeve, thereby providing an assembly configured for insertion into a medical object requiring protection; the sleeve having a proximal segment and a distal segment, and a distal end, the proximal segment extending from the proximal end in a distal direction, the distal segment extending from the distal end in a proximal direction, the diameter of the distal segment gradually decreasing toward the distal end; the sleeve comprising a sleeve wall comprising a water-resistant polymer material, the sleeve wall having a diameter of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm. The sleeve has an average thickness of µm; the sleeve further includes at least one draw wire integrated or attached to the proximal section of the sleeve; wherein the sleeve (or sleeve wall) includes a weak portion at least in the distal section, the weak portion enabling the distal section to fracture when an axial force is applied to the distal section by the elongated device.
[0067] The invention also includes a method of manufacturing an assembly comprising: providing a removable pin shaped to form a cannula, or providing an elongated medical device, and optionally coating the pin or the elongated medical device with a solvent; applying a first layer of water-resistant polymer material to the pin or the elongated medical device; forming at least one structurally weak portion (such as a slit or groove, e.g., a longitudinally scored area / fractured area / tear area / such as a scoring line) in the first inner layer; optionally applying a second layer of water-resistant polymer material covering at least the structurally weak portion, such as the groove, the first layer and the optional second layer constituting a cannula wall; optionally removing the pin and inserting the elongated medical device into the cannula. Attached Figure Description
[0068] Figure 1 and Figure 2A A side view of the sleeve is shown.
[0069] Figure 2B An axial view of the distal end of a sleeve with three notched zones / notched lines is shown.
[0070] Figure 3A A cross-sectional view of a portion of a casing wall with two layers is shown, in which a slit in the thicker layer constitutes a structural weak point (score area, score line).
[0071] Figure 3B A cross-sectional view of a two-layered sleeve is shown, in which the serrated area and serrated lines represent slits in the thicker layer.
[0072] Figure 3C A cross-sectional view of a portion of the casing wall is shown, where the structural weakness is illustrated by a reduction in the casing wall thickness.
[0073] Figure 4 A cross-sectional view is shown of a specific weak point achieved by the overlapping sleeve wall forming a fractured groove line.
[0074] Figure 4 Show
[0075] Figure 5 A cross-sectional view of a two-layered cannula is shown, in which the notch lines are formed by slits passing through the thick layer and covered by the thin layer. The cannula accommodates a specific, slender medical device.
[0076] Figures 6A to 6E illustrate an assembly including a hollow cylindrical member within a cannula. A catheter is inserted into the interior of the hollow cylindrical member for delivering a live cell suspension to the distal end of the cannula. By rupturing the cannula, the suspension can be absorbed into the surrounding soft tissue. Disclosure of the invention
[0077] Components
[0078] The component includes at least one elongated device and a water-resistant sleeve, wherein the sleeve at least accommodates the distal segment of the elongated device. It can be inferred that the component preferably has an elongated shape. The component is slender, at least the portion to be inserted into soft tissue is slender, as the component is designed / constructed to insert a medical object requiring protection into soft tissue such as nerve tissue. The average diameter of the component is less than about 5 mm, preferably less than 2 mm. The average diameter of the component may be less than 100 µm for some applications. The elongated device of the component may include several objects / elements. Importantly, the elongated device as a whole has sufficient stiffness to allow insertion into a variety of soft tissues. Stiffness can be achieved by elements that impart rigidity (such as a single elongated object); alternatively, the overall stiffness of the elongated device can be partially provided by several different objects / elements. The elongated flexible object can be stiffened by applying a material that provides stiffness (structural integrity) when dry and disintegrates and / or dissolves and / or alters mechanical properties upon contact with tissue fluid. Specific flexible elongated objects / elements / devices constitute microelectrodes, which are stiffened by applying a matrix material that has a stiffening effect when dry. This stiffening matrix material disintegrates and / or dissolves and / or alters its mechanical properties upon contact with soft tissue (soft tissue fluid). If the elongated device constitutes only one object / element, then the element must be stiff enough to allow insertion into soft tissue.
[0079] Casing materials and properties
[0080] The sleeve is made of one or more polymer materials and has an average sleeve wall thickness of less than 100 µm, less than 50 µm, less than 40 µm, less than 30 µm, less than 20 µm, or less than 10 µm. The average sleeve wall thickness can be from 0.1 µm, 0.2 µm, 0.5 µm, 1 µm, 3 µm, or 5 µm. Any lower and upper limits can be combined. The average thickness can be from 0.2 µm to 50 µm, from 5 µm to 15 µm, or from 1 µm to 2 µm.
[0081] The sleeve preferably has an elongated shape, at least at its distal end, to accommodate the elongated device. The sleeve is water-resistant or waterproof.
[0082] The casing wall can be made of non-water-degradable or non-soluble materials.
[0083] The cannula is made of a polymer material. Any polymer material can be selected, provided that the cannula is water-resistant, capable of inducing controlled rupture at weak points in the cannula, and suitable for providing a distal segment and distal end with a shape that facilitates insertion into soft tissue while minimizing soft tissue damage.
[0084] The casing material is preferably a water-insoluble, and preferably flexible, polymer material.
[0085] The polymer material for the sleeve can be selected from water-resistant, preferably water-insoluble polymer materials that can be applied by dip coating, spraying, and vapor deposition such as physical vapor deposition (PVD) and chemical vapor deposition (CVD). Vapor-depositable polymer materials are the preferred category of polymer materials.
[0086] The polymer material can be selected from polyurethane, polyvinyl alcohol, polyimide, synthetic rubber and natural rubber, polytetrafluoroethylene, silicone, and polymer materials including those with para-substituted xylene groups as the main chain, including polymers based on parylene.
[0087] Polymers based on parylene are particularly preferred because they can be vapor-deposited. Examples of parylene-based polymers include parylene-based polymers, such as parylene N, parylene C, parylene D, parylene F (AF-4), and parylene HT. Parylene C is particularly preferred for some applications.
[0088] The polymer sheath material may also be flexible to some extent. The polymer sheath material may have an elongation at break of at least 10%, such as from about 10% to about 250%, such as from about 25% to about 100%.
[0089] The diameter of the distal section of the sleeve gradually decreases towards the distal end. This tapering shape is preferably symmetrical about a central axis.
[0090] The tapering shape can be conical, hyperbolic, or parabolic.
[0091] The tapering region at the distal end may be configured with longitudinal ridges and / or grooves evenly distributed along the circumference. The tapering region at the distal end may have any number of ridges and grooves evenly distributed along the circumference, such as at least three or at least four ridges and / or grooves evenly distributed along the circumference.
[0092] The distal section of the sleeve, such as the tapered portion in the distal end region, may be hemispherical or dome-shaped, with a base radius of less than 200 µm, more preferably less than 100 µm. The distal end may be blunt.
[0093] The weak point in the casing wall can be characterized as a scored area / fractured area / tear area / fractureable seal, or as a scored line / fractured line / tear line / fractureable seal. Scored lines / fractured lines / tear lines / fractureable seals are interchangeable. This weak point can be formed by reducing the thickness of the polymer material, or by overlapping adjacent wall segments (overlapping wall segments). The thickness reduction preferably has a longitudinal extension. The thickness reduction can be continuous or discontinuous, such as an indentation along a defined path. The width of the weak point in the form of a scored line can be any value, as long as the casing fractures controllably along the scored line. The width of the scored line can be less than 500 µm, less than 400 µm, less than 300 µm, less than 200 µm, less than 100 µm, less than 50 µm, less than 15 µm, less than 10 µm, or less than 5 µm. The width of the scribe lines can be from 0.1 µm, 0.2 µm, 0.3 µm, 0.4 µm, 0.5 µm, 0.6 µm, 0.7 µm, 0.8 µm, 0.9 µm, and 1.0 µm. The thickness of the scribe lines is less than 80%, 70%, 60%, 50%, 40%, 30%, 20%, 10%, 5%, 1%, 0.1%, and 0.01% of the average thickness of the casing wall.
[0094] One embodiment of the casing wall may include two or more layers, preferably two layers. The layer closest to the central axis of the casing, preferably the inner layer, is significantly thicker than the outer layer. The inner layer is preferably 1.5 to 20 times thicker than the outer layer, more preferably 2 to 15 times thicker. The polymer materials of the two layers may be the same or different materials. Preferably, these layers are made of the same polymer material, so that they adhere and bond properly.
[0095] One embodiment of the weak section of the casing can be achieved by a casing whose wall is formed of a polymer material and includes at least one through slit covered by a material different from the casing wall (such as a non-polymer adhesive), thereby providing a water-resistant, controllable fracture weak section.
[0096] Another implementation of the weak section of the sleeve is achieved, for example, by cutting the sleeve wall to form a slit that is not covered by another layer or adhesive.
[0097] The location of weak points and scoring lines
[0098] The weak point is preferably confined to a specific area / volume of the sleeve. The weak point can have any extent of extension, as long as it causes controlled rupture of the sleeve while minimizing or even eliminating sleeve fragments remaining in the soft tissue after removal. Preferably, the weak point is arranged such that the sleeve can be removed entirely from the soft tissue. The extent of the weak point can be longitudinal, curved, serrated, or meandering. When presented in two-dimensional space, the area of the weak point preferably has an overall longitudinal extension. The weak point can be characterized as a scored area, a fractured area, a tearing area, or a fractured seal that causes controlled rupture of the sleeve by, for example, radial and / or axial forces. The axial force is preferably applied in the distal segment of the sleeve, preferably at the distal end of the sleeve. The radial force can be applied by the expansion of the sleeve. The axial force can be provided by the interaction between the sleeve and the elongated device. Scratched areas, breakable areas, tearable areas, and fractured seals generally refer to intentionally introduced mechanical weak points that allow material to fracture, tear, or separate in a controlled manner along such areas. These areas generally extend longitudinally. The weak point can exhibit various geometric shapes, such as serrated, curved, or meandering, but preferably generally follows a longitudinal extension. The weak point can also be characterized as continuous or discontinuous.
[0099] In the context of a weak point, the region preferably has a linear extension. Therefore, the scored area can be characterized as a score line.
[0100] The weak points in the casing can be addressed by reducing the thickness of the casing wall, and in some applications, this manifests as a through-cut with a very limited width.
[0101] Weak points in the sleeve can also be represented by a through slit, referred to herein as a slit for simplicity. The slit is very fine (very narrow) and is preferably formed by cutting. In the context of this invention, the slit extends completely through the sleeve material (wall), i.e., a through slit. The width of the slit is typically less than 5 µm, less than 4 µm, 3 µm, 2 µm, or 1 µm.
[0102] A non-penetrating slot, also referred to herein as a groove or notch, can have any width to form a weak section that can be controlled to fracture by axial and / or radial forces. A groove can be much wider than a slot because it does not extend completely through the casing wall. However, there is no lower limit to the width of the groove. The groove can have any width as long as the casing can fracture in a controlled manner. Typical groove widths are less than 0.5 mm, less than 0.4 mm, less than 0.3 mm, less than 0.2 mm, and less than 0.1 mm.
[0103] In embodiments where the slit is covered by a thin layer of any material (such as a water-resistant material or adhesive), the width of the slit can have any value of the groove width.
[0104] When a sleeve is manufactured by, for example, depositing two layers (a first inner layer and a second outer layer on top of the first layer) on a pin, a slit is cut in the first layer. When covered by the second layer, the slit in the first layer becomes a groove. Since the slit becomes a groove, the slit can have any width required for the groove, provided that the slit is covered by, for example, another layer or any other material (e.g., adhesive).
[0105] Compared to slits, grooves offer improved water resistance. Scoring lines can be created using either slits or grooves.
[0106] The sleeve can be formed using polymers (such as parylene-based polymers) that enable vapor deposition (chemical vapor deposition (CVD) and physical vapor deposition (PVD)). A first polymer is deposited on an elongated device of the pin or component to form a first inner layer. Before depositing a second polymer to form a second outer layer on the inner layer, or at least cover the slit, at least one through slit is cut through the inner layer. This forms a sleeve wall with two layers, wherein the weak point is manifested as a combination of the through slit in the inner layer and the outer layer covering the slit, thereby forming a non-through slit, i.e., a groove or recess.
[0107] For some applications, another implementation of the sleeve's weak point is to extend completely through the slit in the sleeve material, i.e., through the slit. The opposing slit surfaces can adhere through non-covalent forces (such as hydrophobic interactions, van der Waals interactions) and / or the material's shape memory effect.
[0108] The weak point of the casing can preferably be controlled to rupture by applying an axial force to the distal segment of the casing, preferably the distal end of the casing, which includes at least one weak point. The axial force is no more than 5 N, less than 5 N, less than 4 N, less than 3 N, or less than 2 N. The axial force is applied by an elongated device in the casing, preferably by moving at least the distal segment of the casing towards the proximal end.
[0109] A weak point in a sleeve comprising at least two layers can be achieved by completely cutting through the inner layer to form a slit before applying the outer layer. The outer layer may not need to be applied completely around the inner layer. Applying an outer layer with a slit that at least covers the inner layer may suffice. The combination of a through slit in the inner layer and an outer layer covering the slit provides a weakened area or notched area / line in the form of a non-through slit, groove, or recess. The width of the slit or groove in one of these layers (e.g., the inner layer) may be less than 500 µm, less than 200 µm, less than 100 µm, less than 50 µm, less than 40 µm, less than 30 µm, less than 20 µm, less than 10 µm, or even less than 5 µm. After cutting through one of these layers (e.g., the inner layer), the two opposite sides of the wall may still be in contact with each other, i.e., the opposite sides of the wall are in physical contact, thus providing a very narrow slit less than 1 µm wide before applying the outer layer covering the slit.
[0110] The weak point can also be formed by cutting the sleeve wall and radially adjusting the two opposing wall segments so that these segments preferably overlap in the longitudinal region. The overlap can be further secured with an adhesive (such as a non-polymer adhesive) to provide a water-resistant, controlled-breakage weak point.
[0111] The weak point is located in the distal section of the casing, for example, at least one score line in the distal section of the casing. The score line preferably bisects the distal end, preferably extends proximally, preferably on one side of the casing, and preferably arranged substantially along the axis of the casing.
[0112] The casing preferably has at least one notch line arranged substantially along the entire longitudinal axis of the casing, the notch line dividing the distal end (constriction) substantially symmetrically.
[0113] The sleeve preferably includes at least two weak points that divide the distal end and further intersect each other in the distal end, and a scoring line.
[0114] According to one embodiment, the sleeve includes at least one notch at its proximal end, the notch preferably having a triangular geometry and preferably oriented such that one of its edges (or vertices) points toward the distal end, preferably substantially aligned along the longitudinal axis of the sleeve, and preferably associated with a scoring line at its vertices. The association of the distal vertices of the triangular notch with the scoring line facilitates the breaking of the longitudinal scoring line extending from the distal segment / distal end.
[0115] Water-soluble / water-degradable materials
[0116] In several embodiments, the elongated device includes a water-soluble and / or water-degradable material as an element that imparts rigidity. Such water-soluble and / or water-degradable materials are also referred to as matrix materials. The matrix material preferably has rigidity when dried, that is, when dried, the matrix imparts to the elongated device sufficient rigidity for insertion into soft tissue and sufficient structural rigidity to cause the sleeve to rupture.
[0117] The matrix material can be a gelling agent, which is preferably in a dry state and preferably includes less than 20%, less than 10%, or less than 5% water by weight.
[0118] The matrix material can be selected from various animal-derived gelatins that can be used as gelling agents, such as bovine gelatin, poultry gelatin, poultry gelatin, and tuna gelatin. Mammal-derived gelatins are preferred due to their superior gelling ability at body temperature. To increase rigidity, chemically cross-linked gelatin is preferred because it degrades more slowly in vivo. Examples of effective gelatin cross-linking agents are bis(vinylsulfonyl)methane and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. Another useful cross-linking method is through ultraviolet (UV) radiation. The degradation rate in vivo can be controlled by the degree of cross-linking, which in turn can be controlled by the amount of cross-linking agent used or by controlling the UV radiation exposure used to cross-link a given amount of gelatin.
[0119] Other aqueous biocompatible gels of the present invention include carbohydrate gels. Carbohydrate gels that can be used in the present invention include arabinogalactan gels, arabinoxylan gels, galactan gels, galactomannan gels, lichenomannan gels, and xylan gels, but also include cellulose derivatives such as hydroxymethylpropyl cellulose, and are formed by contacting an aqueous medium, particularly an aqueous body fluid, with a gelling agent selected from: arabinogalactan, arabinoxylan, galactan, galactomannan, lichenomannan, xylan, hydroxymethyl cellulose, and other cellulose derivatives that form gels upon contact with an aqueous medium.
[0120] Other aqueous biocompatible gels of the present invention include protein gels. Besides gelatin derived from animal sources, protein gels that can be used in the present invention include whey protein gels, soy protein gels, and casein gels, which are formed by contacting an aqueous medium, particularly an aqueous body fluid, with a gelling agent selected from whey protein, soy protein, and casein.
[0121] Other aqueous gels still applicable to the present invention can be formed by contacting an aqueous medium, particularly an aqueous body fluid, with a gelling agent selected from the group consisting of: arabinogalactan; arabinoxylan; galactan; galactomannan; lichenomannan; xylan; cellulose derivatives, such as hydroxymethylpropyl cellulose; whey protein; soy protein; casein; hyaluronic acid; chitosan; gum arabic; carboxyvinyl polymers; sodium polyacrylate; carboxymethyl cellulose; sodium carboxymethyl cellulose; pullulan; polyvinylpyrrolidone; guilargine gum; pectin; xanthan gum; tragacanth gum; alginic acid; polyoxymethylene; polyimide; polyether; chitosan; polyglycolic acid; polylactic acid; polyglycolic acid Copolymers of polylactic acid; copolymers of polylactic acid and polyethylene oxide; polyamides; polyanhydrides; polycaprolactone; maleic anhydride copolymers; polyhydroxybutyrate copolymers; poly(1,3-bis(p-carboxyphenoxy)propane anhydride); polymers formed by copolymerization with sebacic acid or with polyterephthalic acid; poly(glycolic acid-co-trimethylene carbonate); polyethylene glycol; polydioxanone; polypropylene fumarate; poly(ethyl glutamate-co-glutamate); poly(tert-butoxycarbonylmethyl glutamate); polycaprolactone; poly(caprolactone-co-butyl acrylate); polyhydroxybutyrate and its copolymers; poly(phosphazene); poly(D,L-lactide-co-caprolactone); poly(glycolic acid-co-co-trimethylene carbonate); poly(glycolic acid ... -co-caprolactone); poly(phosphate); poly(amino acid); poly(hydroxybutyrate); polyphenolic peptide; maleic anhydride copolymer; polyphosphazene; polyimino carbonate; poly[(7.5% dimethyl-trimethylene carbonate)-co-(2.5% trimethylene carbonate)]; polyethylene oxide; hydroxypropyl methylcellulose; poly(ethylene-co-vinyl acetate); isobutylene-based copolymers with at least one other repeating unit (such as butyl acrylate: butyl methacrylate); substituted styrene, such as aminostyrene, hydroxystyrene, carboxystyrene, sulfonated styrene; homopolymers of polyvinyl alcohol; polyvinyl alcohol with at least one other repeating unit (such as ethylene) Copolymers of cyclohexyl ether; hydroxymethyl methacrylate; hydroxyl or amino-terminated polyethylene glycol; acrylate-based copolymers such as methacrylic acid, methacrylamide, hydroxymethyl methacrylate; ethylene vinyl alcohol copolymers; silicone-based copolymers of aryl or alkyl siloxanes with at least one repeating unit; polyurethane; heparan sulfate; RGD peptide; polyethylene oxide; chondroitin sulfate; YIGSR peptide; keratin sulfate; VEGF mimic peptide; perlecan (heparan sulfate proteoglycan 2); laminin α-1 chain peptide containing lleLys-Val-Ala-Val (IKVAV); modified heparin; fibrin fragments. Other embodiments of the invention
[0122] The weak point can be achieved by a sleeve comprising one or at least two layers, preferably two layers, namely an inner first layer and an outer second layer (inner / outer being relative to the central axis of the sleeve / assembly). The inner layer includes at least one through slit and / or groove to form opposing wall segments that are radially displaced and arranged to overlap each other, thereby forming overlapping wall segments. The wall segments can be further secured by applying an outer layer covering at least the overlapping wall segments or alternatively by applying a water-resistant material such as a non-polymer adhesive.
[0123] The weak point can be achieved by a sleeve comprising at least two layers, preferably two layers, namely an inner first layer and an outer second layer (inner / outer being relative to the central axis of the sleeve / assembly). The inner layer includes a slit covered by the outer layer, thereby forming a groove or recess. The outer layer can be the same as or a different polymeric material than the inner layer, or another material, such as a non-polymer adhesive.
[0124] The weak point can be placed only in the far end of the protective sleeve.
[0125] The weak part preferably forms at least one scribing area / scribing line, which extends at least around the distal portion of the distal segment.
[0126] The weak point can be achieved by a groove line extending from the distal end towards the proximal end.
[0127] The weak point of the sleeve can be achieved by at least one notch line that substantially divides the distal end region.
[0128] The weak section of the sleeve can be achieved by dividing the distal end region and having at least two grooves that intersect each other in the distal end region.
[0129] The weak point of the sleeve can be achieved by at least two scoring lines that extend at least around the distal end region and intersect each other in the distal end region. Preferably, the at least two scoring lines are arranged substantially uniformly around the circumference at any axial position in the distal end region. Preferably, the at least two scoring lines are arranged (spaced apart) around the sleeve axis at approximately equal angular intervals (angles) (when viewed axially in the proximal direction).
[0130] Typically, it is preferred that all the serrations intersect each other in a very restricted area that can be characterized as a point (or intersecting region / intersection). This intersection point preferably coincides with the farthest tip of the distal end.
[0131] When viewed from the distal end in the proximal direction, the number of scoring lines (referred to as distal end scoring lines) around the sleeve axis, in the case of at least two scoring lines, preferably follows the following equation: the number N of scoring lines extending around the distal end region is equal to the number N+N of distal end scoring lines around the sleeve axis when viewed from the distal end in the proximal direction (along the central axis). Two scoring lines form four distal end scoring lines. Three scoring lines form six distal end scoring lines.
[0132] The angle between the two distal end scoring lines is preferably varied by a maximum of 10° and a maximum of 5°.
[0133] The weak point can also be addressed by at least three scoring lines, all extending around the distal end region. Preferably, the at least three scoring lines are arranged substantially uniformly around the circumference at any axial location within the distal end region. Preferably, the at least three scoring lines are arranged at approximately equal angular intervals (spaced apart) around the sleeve axis (when viewed axially in the proximal direction).
[0134] Preferably, at least one score line extends to the proximal end of the sleeve (indicating that the sleeve can break into two pieces). According to one embodiment, at least one score line extending to the proximal end of the sleeve terminates (connects to the edge) at the edge (or vertex) of a triangular notch pointing towards the distal end of the sleeve at the proximal end of the sleeve.
[0135] According to one embodiment, the weak point is implemented by at least two scoring lines, all of which extend around the distal end region. Preferably, the at least two scoring lines are arranged substantially uniformly circumferentially at any axial position within the distal end region. Preferably, the at least two scoring lines are arranged at approximately equal angular intervals (spaced apart) around the sleeve axis (when viewed axially in the proximal direction), with one scoring line extending to the proximal end of the sleeve. Preferably, only one scoring line extends from the distal segment, the distal end, to the proximal end of the sleeve, preferably to the distal apex of a notch in the proximal end of the sleeve, the notch having a predominantly triangular shape.
[0136] According to one embodiment, the weak point is implemented by three scoring lines, all of which extend around the distal end region, thereby forming six distal end scoring lines. Preferably, the three scoring lines (forming six distal end scoring lines) are arranged substantially uniformly around the circumference at any axial position within the distal end region. Preferably, the three scoring lines are arranged at approximately equal angular intervals (spaced apart) around the sleeve axis (when viewed axially in the proximal direction), with one scoring line extending to the proximal end of the sleeve. Preferably, only one scoring line extends from the distal segment, the distal end, to the proximal end of the sleeve, preferably extending to the distal apex of a proximal notch in the proximal end of the sleeve, which preferably has a substantially triangular shape.
[0137] According to one embodiment, the sleeve includes at least one recess at its proximal end, the recess preferably having a triangular geometry and preferably oriented such that one of its edges (or vertices) points toward the distal end, preferably substantially aligned along the longitudinal axis of the sleeve. The edge of the triangularly shaped recess pointing toward the distal end is preferably associated with a scoring line.
[0138] The weak points can be non-uniform in terms of fracturing susceptibility under mechanical force. The weak points can be designed with selected weaker portions that induce fracture upon expansion or stretching in a direction transverse to the principal axis of the weak points, thereby increasing control over the fracture process. For example, the notch line can be designed to fracture first in the distal segment or distal end (tip) or a region nearby, and then fracture axially, preferably substantially in a straight line along the axis of the sleeve, but other configurations are conceivable within the scope of this invention.
[0139] In one embodiment, the protective sheath of the elongated device has a distal segment typically configured to facilitate pushing soft tissue aside during insertion.
[0140] In one embodiment of the component, the protective sleeve includes a distal segment configured with a radius that gradually decreases toward the distal end.
[0141] In one embodiment, the distal end region of the protective sheath has a blunt structure that helps to push aside tissue during insertion and reduce the risk of accidental damage to blood vessels.
[0142] In one embodiment, the protective sleeve has a distal section with a tapered shape and at least one serrated line extending from the distal end of the protective sleeve to the proximal end. The protective sleeve with the tapered distal end region may have a sharp tip or a blunt end, depending on the application of the elongated device.
[0143] The distal end of the sleeve may have a dome or hemisphere shape with a radius of less than 200 µm, preferably less than 100 µm.
[0144] In one embodiment, the protective sleeve has a circular, preferably partially spherical, distal segment with at least two intersecting grooves, the intersection preferably located at the distal end. Preferably, at least one groove extends proximally toward the proximal end of the protective sleeve, but does not reach that proximal end.
[0145] In one embodiment, the protective sheath of the component has a distal segment typically configured to facilitate penetration of a blood vessel and reduce the damaging effects of such penetration, for example, for injecting medication or other medical objects into the bloodstream. In such embodiments, this distal end may include a sharp edge for penetrating the vessel wall, for example, when using a medical device as an injection needle or as a drug delivery catheter. This embodiment reduces the risk of bleeding during and after catheter insertion into a blood vessel. Damage to the blood vessel can be reduced by avoiding the cutting effect of the sharp distal portion of prior art injection needles. Once inside the blood vessel, the protective sheath is withdrawn, leaving the catheter inside the vessel. A preferably hollow, rigid needle core can be used to provide structural support during insertion.
[0146] In implementations of the component, the protective sleeve is configured to be removed from the entire soft tissue component after a fracture occurs in a weak area, such as a scoring line.
[0147] In implementations of the component, the protective sleeve includes at least one flange to control insertion depth and facilitate removal of the protective sleeve after insertion into soft tissue. The flange is integral with or at least adhered (e.g., by adhesive) to the protective sleeve and protrudes from it. The flange can have any shape, such as rectangular or circular, and preferably protrudes radially more than 10 µm relative to the outer surface of the sleeve. Suitable radial protrusions are up to 5 mm, preferably up to 10 mm, but can be longer. Suitable axial lengths of the protrusion (flange) are between 0.1 and 10 mm, preferably between 1 and 5 mm, but can be longer. The flange may be equipped with one or more structures that allow attachment, for example, any type of wire or handle, for easy manipulation.
[0148] In embodiments without flanges, the protective sleeve includes pull cords securely attached (e.g., with adhesive) to the proximal portion of the sleeve, allowing the sleeve to be pulled proximally. These pull cords preferably have handles at their ends for easy removal of the protective sleeve.
[0149] In one embodiment, the elongated device includes a connection means that can be engaged with a guiding system to support insertion into soft tissue.
[0150] In some embodiments, the assembly further includes a rigidifying element that is at least partially surrounded by the component. The rigidifying element assists in both insertion of the assembly and protection against breakage of the sheath. In some embodiments, the rigidifying element may have an elongated cylindrical shape, for example, made of stainless steel. Preferably, the rigidifying element is removable after the elongated device has been properly positioned in soft tissue and has come into contact with bodily fluids.
[0151] In one embodiment, the elongated device includes at least one element that provides temporary or permanent rigidity, which can provide a support structure for the flexible or fragile parts of a medical object.
[0152] In one embodiment of the component, the enclosed elongated device contacts the protective sleeve. For example, the protective sleeve and the elongated device may be in frictional contact, for example, by treating either of their contact surfaces or a suitable portion of that surface.
[0153] In embodiments of the component, the elongated device includes at least one rigid element selected from biocompatible materials that are soluble, degradable, or otherwise affected upon contact with bodily fluids or tissue. Soluble and / or degradable materials suitable as part of an implantable elongated device, such as rigid elements supporting the insertion of flexible microelectrodes, are well known to those skilled in the art. Materials soluble in (including water) or degradable by such bodily fluids or water may include, for example, biocompatible carbohydrate and / or protein materials, such as glucose and albumin. Alternatively, the biocompatible material gels upon contact with aqueous bodily fluids, such as gelatin or hyaluronic acid, or a mixture of gelatin or hyaluronic acid with carbohydrate and / or protein materials. Other examples are available from WO 2018 / 217147 and WO 2022 / 005386.
[0154] In one embodiment of the component, the enclosed elongated device extends axially and has an average diameter of about 5 mm or less. Preferably, this diameter is less than about 4 mm, less than about 3 mm, less than about 2 mm, or less than about 1 mm. The length of the elongated device is preferably less than 15 cm, less than 10 cm, or less than 5 cm.
[0155] In embodiments of the component, the enclosed elongated device includes at least one flexible microelectrode or constitutes a flexible microelectrode, such as a bundled or arrayed arrangement of microelectrodes or a multichannel microelectrode. The microelectrode / multichannel microelectrode can be flexible and embedded within a rigid support structure / matrix material, which may include, for example, rigid materials soluble in bodily fluids as described above. Microelectrodes are examples of elongated medical objects and therefore fall into the category of elongated devices.
[0156] In some embodiments of the component, a protective sheath surrounds an elongated device including a microelectrode comprising a proximal insulating section and a distal non-insulated section. The microelectrode is centrally disposed within a flexible polymeric encapsulation / sheath / housing attached, preferably slidably, to the insulating section of the microelectrode by means of a flexible polymeric material wall dividing the housing into proximal and distal compartments. The non-insulated section of the microelectrode is entirely disposed within the distal compartment, which includes means for allowing the microelectrode to perform electrical monitoring or electrical stimulation of neural tissue surrounding the housing without direct contact between its non-insulated section and neural tissue. Embodiments of such elongated devices are disclosed in WO 2020 / 141997 and WO 2022 / 005386, the contents of which are incorporated herein by reference. Therefore, the contents of WO 2020 / 141997 and WO 2022 / 005386 should be considered as explicitly disclosed herein.
[0157] In some embodiments of the component, a cannula surrounds an elongated device including a plurality of microelectrodes disposed in a soluble guiding structure connected to a proximal guiding member including means for axially displacing the microelectrodes distally to a defined tissue contact location, as described in WO2022 / 124957, which is incorporated herein by reference.
[0158] In embodiments of the component, the elongated device may include: an electronic chip comprising semiconductor material and used for, for example, amplifying cellular electrical signals or transmitting signals; an energy source, such as a battery; and a biocompatible fluid, optionally comprising at least one therapeutic agent and / or cells. It may also contain toxic materials intended to damage specific tissues, such as cancerous tissue or tumors.
[0159] In one implementation, the component includes a sensor attached to the inside of the protective sheath. This sensor is operatively connected to electronics external to the soft tissue, which are capable of processing and transmitting data received from the sensor. The sensor can detect fluid leakage into the protective sheath before sheath ruptures, or it can be configured to monitor the insertion process. An example of a sensor that can be used to detect fluid leaks includes two separate electrodes, which are insulated except for their distal ends, and these electrodes are in contact with electronics to measure the impedance between the two electrodes. A leak of sufficient bodily fluid to short-circuit the two electrodes will cause a decrease in impedance between them. This, in turn, will inform the operator that a leak has occurred.
[0160] In implementation, the components include markers for improving detection by ultrasound imaging, X-ray, computed tomography (CT), or magnetic resonance imaging (MRI), which can aid in the precise localization of medical objects. The markers may be provided as disclosed in WO 2018 / 222101, the contents of which are incorporated herein by reference.
[0161] In this embodiment, the component has a smooth shape. The surface of the protective sheath may be coated with a friction-reducing agent. In one example, the coating comprises a mucilaginous composition containing glycoproteins and / or proteoglycans, suitable for coating a protective sheath surrounding a medical object with a rough surface or surrounded by a fibrous web. In another example, the friction-reducing agent is a thin layer of ice that becomes super-slippery upon thawing.
[0162] In implementations of the component, the outer surface of the protective sheath is coated with a biodegradable material capable of releasing drugs, such as providing nutritional support to the host tissue receiving the implant and / or the living cells to be implanted. Such materials include anti-inflammatory agents, nutrient factors, neurotransmitters (such as GABA or glycine), or anesthetics (such as benzodiazepines) to reduce the metabolic demands on the implanted local tissue. It may also be coated with an antimicrobial material to prevent or at least reduce the risk of infection. It may also be coated with a pH-buffering material to reduce the risk of harmful pH changes during and after the insertion procedure.
[0163] Method of inserting a slender device
[0164] One aspect of the invention relates to a method of inserting an elongated device, comprising at least one element imparting rigidity, into soft tissue via a water-resistant sleeve that accommodates at least the distal segment of the elongated device.
[0165] The components used in this method, including the elongated device and the water-resistant sleeve, may have the features presented herein.
[0166] More specifically, the present invention relates to a method for inserting an elongated device comprising at least one rigid element into soft tissue, such as nerve tissue, the elongated device having an overall diameter of less than about 5 mm, preferably less than 1 mm, the method comprising receiving at least a portion of the elongated device in a water-resistant sleeve, thereby providing an assembly configured for insertion into a medical object requiring protection, the water-resistant sleeve having a proximal segment and a distal segment, the proximal segment extending from the proximal end in a distal direction, the distal segment extending from the distal end in a proximal direction, the diameter of the distal segment gradually decreasing toward the distal end, the sleeve comprising a sleeve wall comprising a water-resistant polymer material, the sleeve wall having a diameter of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm. The sleeve has an average thickness of µm and further includes at least one draw wire integrated or attached to the proximal section of the sleeve, wherein the sleeve (or sleeve wall) includes a weak portion at least in the distal section, which allows the distal section to fracture when an axial force is applied to the distal section by an elongated device.
[0167] Another embodiment relates to a method of inserting an elongated device comprising at least one rigid element into soft tissue, such as nerve tissue, the elongated device having an overall diameter of less than about 5 mm, preferably less than 2 mm, the method comprising receiving at least a portion of the elongated medical device in a water-resistant cannula, thereby providing an assembly configured for insertion into a medical object requiring protection, the cannula having a proximal segment and a distal segment, and a distal end, the proximal segment extending from the proximal end in a distal direction, the distal segment extending from the distal end in a proximal direction, the diameter of the distal segment gradually decreasing toward the distal end, the cannula including a cannula wall comprising a water-resistant polymer material, the cannula wall having a diameter of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm. The sleeve has an average thickness of µm and further includes at least one withdrawal aid and / or positioning element integrated or attached to the proximal segment of the sleeve, wherein the sleeve (or sleeve wall) includes a weak portion at least in the distal segment, which enables the distal segment of the sleeve to rupture by applying an axial force and / or a radial force (when an axial and / or radial force is applied).
[0168] The axial force applied to the distal segment of the casing is preferably provided by applying an axial force (in the proximal direction) to at least one drawwire to move at least that distal segment of the casing in the proximal direction. The drawwire can move in any direction, as long as the result is that at least that distal segment of the casing moves in the proximal direction. Preferably, the drawwire moves in such a way that the movement produces an axial force vector.
[0169] The axial force is preferably applied after the component has been placed within the tissue.
[0170] According to one embodiment, the axial force applied to the distal segment by the elongated device is less than 5 N, preferably less than 2 N, such as less than 1 or less than 0.6 N.
[0171] The method of inserting an elongated device into soft tissue may additionally include any of the following operations: enclosing at least a portion of the distal segment of the elongated object within the cannula to form an assembly; introducing the assembly into the soft tissue; properly positioning the assembly at a predetermined location within the soft tissue; rupturing or breaking at least a weak point of the cannula by applying radial and / or axial forces to the cannula, thereby allowing at least tissue fluid to enter and contact the medical object; and removing the cannula from the soft tissue.
[0172] According to one embodiment, after the cannula ruptures, the component or portions thereof are removed from the soft tissue.
[0173] Preferably, by moving at least the distal segment of the casing toward the proximal end, the weak area within the distal segment of the casing is intentionally fractured or broken, thereby applying an axial force to the distal end from inside the casing toward the distal end.
[0174] In one embodiment of the method, an axial or radial pressure is applied to the protective sleeve by an elongated device to cause the weak area, such as the scoring line, to break.
[0175] In an implementation of this method, sleeve expansion (i.e., radial expansion and / or axial expansion) can generate sufficient force on the sleeve to cause the weak area to rupture.
[0176] In embodiments of this method, the fractured sleeve is removed entirely, or in any number of portions corresponding to the number of pull wires or flanges attached to or integrated into the proximal segment, preferably the proximal end, of the sleeve. One example is a sleeve with four pull wires attached proximal to portions of the sleeve separated by score lines. The sleeve is fractured to create four portions, each attached to a pull wire. Preferably, the score lines are arranged such that the sleeve can be removed entirely.
[0177] In embodiments of this method, the elongated device to be implanted comprises living cells or fragments of living tissue or aggregates of living cells. For applications involving the implantation of living cells or tissue fragments, the elongated device preferably comprises a hollow member, preferably a hollow cylindrical member, which preferably provides sufficient rigidity to allow insertion of the component, thereby enabling insertion of a catheter. The medical object, i.e., living cells or fragments of living tissue or any other biological material, is introduced into the cannula via the catheter. To reduce the risk of premature contact with tissue or to minimize the transfer time of the cells to be transplanted, one embodiment of the invention involves first inserting the component of the invention according to any of the foregoing embodiments, which comprises a hollow catheter / component (such as a rigid cylinder), a catheter, and a cannula. The hollow catheter may include living cells or fragments; alternatively, the living cells or fragments may be located in the distal segment, distal end, of an elongated member (e.g., a catheter) configured for axial movement within the hollow catheter. The living cells or fragments may also be present between the elongated device and the cannula. After the cannula ruptures, the living cells or fragments are introduced into the target soft tissue volume. By introducing live cells into the inserted elongated device, cell transfer time can be significantly reduced, thereby mitigating the risk of adverse effects on cells, such as decreased oxygen levels or pH changes within the hollow catheter. Notably, when removing the cannula and elongated device, it is not necessary to eject (inject) the live cells, as they are in direct contact with the target tissue once the protective cannula and elongated device are removed. This also means that when cells are introduced into the tissue, there is little or no pressure on the target tissue.
[0178] After the component of the present invention is inserted into the target tissue, the cell suspension is rapidly transferred to a predetermined soft tissue volume, preferably via a catheter introduced into a rigid cylinder prior to insertion, after which the cannula is rapidly removed. To further reduce transfer time for field delivery, the hollow catheter is preferably equipped with a distal opening and one or more open slots or holes in the wall of its distal portion, through which the suspension of cells or cell aggregates can be exposed to the tissue once the protective cannula ruptures and is withdrawn. The device, including the hollow component (cylinder) and optional catheter, is then removed, leaving the live cells at the intended site in the tissue. If desired, a suspension of live cells or live tissue fragments (or live cells or cell fragments) can be expelled from the elongated medical device during cylinder withdrawal. More preferably, live cells, tissue fragments of live cells, preferably in suspension form, are delivered to the soft tissue without pressure or at least minimal pressure. The suspension of live cells or cell fragments can also be retained in the soft tissue by carefully moving the hollow catheter / component in the proximal direction without substantially moving the suspension and without substantially applying axial pressure to the suspension. The reduction in the transfer time of live cells corresponds to the duration of insertion of the elongated device into soft tissue. The elongated device may be at a temperature below body temperature, such as below 0°C, and may be filled with a frozen cell-free solution prior to insertion, and optionally coated with ice prior to insertion.
[0179] In another preferred embodiment of the method for delivering cells to soft tissue, the components of any of the aforementioned embodiments are first inserted into the target soft tissue, then paused for up to 7 days or longer, before live cells are administered through the elongated device. The cannula is then ruptured, exposing the live cells to the soft tissue. The purpose of this pause is to allow the tissue response (inflammatory response) to subside, thereby providing an environment more conducive to the survival of the live cells.
[0180] The scope of this invention lies in combining the insertion of live cells with the insertion of other medical objects that facilitate the proliferation of live cells in soft tissue. Such medical objects may be microelectrodes for electrically stimulating implanted live cells or for recording signals from implanted or resident cells, as well as photoconductors. This is achieved, for example, by adding the microelectrodes and / or photoconductors to a suspension of live cells or cell aggregates before or after inserting the elongated device into the target tissue.
[0181] In one aspect, the present invention relates to a method of manufacturing an assembly according to any of the foregoing embodiments. The method includes providing a pin (or elongated device) having at least partially a circular, elliptical, rectangular, or rhomboid cross-sectional shape, and a distal segment that narrows radially toward its distal end, suitable for forming a sleeve. The pin may also have ridges along its surface. According to one embodiment, the elongated device presented herein can be used as a tool for producing the geometry of the sleeve. The pin may be hollow or solid and is made, for example, of a polymer, stainless steel, tungsten, glass, crystal, or ceramic. The surface of the pin is preferably smooth to facilitate subsequent processes. Preferably, the pin is coated with a solvent, such as gelatin or a hydrocarbon-based material, to support subsequent processes. Next, a water-resistant polymer layer is applied to the pin or elongated device to form an inner or first layer, and a structural weak point, such as a slit, is formed in this layer using a suitable tool (such as a very sharp knife). Once the slit has been formed, a second layer, preferably an outer layer, of water-resistant material is formed to cover the slit. Preferably, the second outer layer is significantly thinner than the first inner layer. Preferably, the thickness of the first layer is at least two, at least three, at least four, five, six, seven, eight, nine, or ten times the thickness of the second layer. Preferably, the first and second layers are made of the same polymer material. However, the use of different materials is also within the scope of the invention, such as adhesives covering the slits, for example, non-polymer adhesives. If an elongated device is not used as a mold for forming the cannula, the cannula is removed from the pin, and an elongated device, such as those presented herein (e.g., medical objects and optional rigid and / or sensing elements, such as microelectrodes and / or photoconductors)), is introduced into the protective cannula. Alternatively, the second layer may be applied after the pin is removed and the medical object and optional structural elements are inserted.
[0182] In an implementation of the method, the weak point is formed by cutting a slit in one of the layers, preferably the first inner layer.
[0183] In embodiments of this method, these layers are formed from a suitable stretchable parylene (such as parylene C). Other polymers, such as silicone elastomers, polyurethanes, and polyethylenes, are also within the scope of this invention. The application of these layers is performed using various conventional techniques, including, for example, dip coating, spraying, and vapor deposition.
[0184] In an embodiment of the method, the pin may be provided with one or more defined radially projecting portions that serve as molds for one or more radially extending proximal flanges of a protective sleeve, the proximal flanges being continuously formed when at least one layer (preferably a first, thicker layer) of the protective sleeve is applied. These flanges may be provided with attachment tools for pulling wires and for supporting the operation (retraction) of the sleeve.
[0185] The protective sleeve formed by the method of the present invention will have a final wall thickness of less than 100 µm, less than 50 µm, such as 0.2 µm to 50 µm, preferably from 1 µm to 25 µm, and more preferably from 5 µm to 15 µm. However, sections or segments with higher thicknesses may be formed when a particular application requires and / or facilitates its operation, which is also within the scope of the enumerated methods.
[0186] In one embodiment of the method, the method includes providing a removable pin shaped to form a protective sheath (as previously described), and optionally coating the pin with a solvent, such as a carbohydrate-based material or gelatin. A layer of water-resistant polymer material is applied to the pin, and a slit with a width from 5 to 500 µm is formed in the sheath wall. The slit is then covered by forming an overlapping wall portion from the edge of the sheath wall, and the pin is removed, thereby forming a groove or recess and introducing an elongated medical device, which may include a medical object and optional rigid elements, into the sheath. The overlapping wall portion is then covered by a second layer of water-resistant polymer material to form a scoring line. The second layer has a thickness significantly thinner than the first layer and is in the range of 0.5 µm to 10 µm, preferably between 0.5 and 5 µm, and most preferably between 0.8 µm and 2 µm. Alternatively, the first layer is cut through to form a slit without creating a partial wall overlap, but the slit is covered with a second layer of the aforementioned water-resistant polymer material and / or a waterproof material, forming a groove, recess, and thus a scoring line.
[0187] In all embodiments of the manufacture of this component, after the elongated device is inserted into the protective sleeve, the sleeve can be covered with another water-resistant material (such as adhesive) to reduce the risk of leakage caused by unintentional cracking of the protective sleeve.
[0188] This invention is particularly useful when combined with electrodes embedded in water-soluble materials, but can also be used to protect tissue from unintentional cutting at the tip, for example, when introducing a syringe needle into tissue. Within the scope of this invention, a bundle of devices of the invention can be implanted simultaneously, or more preferably, an array of devices (such as an array of components) can be implanted. For this purpose, multiple devices (components) are attached to an insertion system capable of stereotactic implantation of the entire device. Simultaneous implantation has the advantage of reducing the total implantation time of multiple devices (components), which is important in clinical settings.
[0189] It is feasible to include structures that facilitate the opening of weak points (such as rigid elements) in the device to be implanted. Such rigid elements may include, for example, sharp edges that concentrate tearing forces near the tear when the protective sheath is pulled back along the device.
[0190] Useful implementations include: 1) elongated devices for providing gel channels as disclosed in WO 2016 / 032384; 2) elongated medical devices comprising soluble microchannels and microelectrodes and other filaments as disclosed in WO 2020 / 141997 and WO2022 / 005386; and 3) elongated medical devices for use as novel injection needles having protective sheaths, catheters, and optional needle cores with sharp tapered tips.
[0191] Uses of the invention
[0192] The elongated medical device of the present invention can be used to deliver medical objects capable of stimulating, recording, or otherwise interacting with target soft tissue into the soft tissue. Such medical objects include electronics, electrodes, optical fibers, sensors for measuring vital parameters such as oxygen, pH, and blood pressure, living cells or aggregates of living cells, and drugs. The present invention can be used in medical devices that incorporate materials that degrade upon contact with tissue.
[0193] This invention can be used to insert a catheter into a blood vessel.
[0194] This invention can be used for therapeutic purposes, such as to improve the treatment of brain-related conditions, such as neurodegenerative diseases, pain, stroke, depression, sleep disorders, blood pressure disorders, obesity, epilepsy, or endocrine disorders. It can also be used for therapeutic purposes to improve the treatment of endocrine disorders such as diabetes.
[0195] This invention can be used to improve optical visibility during endoscopic examinations. For this application, the cannula material preferably has sufficient transparency to allow the use of optics during insertion.
[0196] This invention can be used to reduce the transfer time required for the time-controlled on-site delivery of fragile or vulnerable medical objects to target soft tissue. The reduction in transfer time is achieved by first implanting the elongated device of this invention into the target tissue. The medical object can then be rapidly transferred into the intact device without compromising its integrity, and the medical object is brought into direct contact with the target tissue after the protective sheath seal ruptures. An example of the invention's use is the implantation of any type of living cells, tissue fragments, or cell aggregates for cell therapy into a desired site in host soft tissue, with the benefits of reduced transfer time, the possibility of pre-preparing host tissue for the implant, and the possibility of reducing / eliminating mechanical stress on the tissue during the actual transfer of the object to the tissue. Description of Detailed Implementation
[0197] Figure 1 A schematic side view of a para-xylene C cannula 100 according to the invention is shown, the cannula 100 having a distal tapered section providing a sharp distal end 110. Weak regions, in the form of, for example, grooves or notches 120 (score lines), are arranged along the main axis of the cannula from the distal end to the proximal end. Sensors 130, 140 are arranged inside the protective cannula to detect the position of the elongated device and any water leakage before insertion into a predetermined location in soft tissue is completed.
[0198] Figure 2A A schematic side view of a cannula of a component 200 according to the invention is shown. The component 200 has a protective cannula with an arcuate, partially spherical distal end segment. The protective cannula has three notches 210, 220, and 230 that intersect in a region of the distal end segment. Notches 210 extend axially from the distal end towards the proximal end but do not reach the proximal end of the protective cannula. Flanges 240A and 240B are provided in the proximal portion of the protective cannula to support its operation. These flanges are arranged with operating tools 242A and 242B, such as suture attachment tools for surgeon-assisted cannula displacement.
[0199] Figure 2B This is a view taken from the axial position of the distal end towards the proximal end, showing three of the six distal end score lines.
[0200] Figure 1 Both arrangements shown in Figure 2 meet the following important requirements: no cannula residue remains in the tissue, posing a risk of tissue reaction. It is also necessary that no loose debris is left after the protective cannula is removed, for example, in cases where a fragile microelectrode needs to be ejected from a medical object (not shown) initially protected by a cannula.
[0201] Figures 3A to 3CIt is a cross-sectional view of the protective sleeve wall, showing the different weak points (score lines). Figure 3A The wall portion 300A of a protective sleeve with a wall thickness of 11 µm is schematically shown. A through slit 320A with a width of less than 1 µm is formed in a first layer 310A having a thickness of approximately 10 µm. A second layer 330A having a thickness of approximately 1 µm is applied over the first layer, covering the slit to form grooves, recesses, and breakable scoring lines.
[0202] Figure 3B Shown in cross-section Figure 3A The arrangement in which the outer protective layer 330A covers the slit 320A.
[0203] Figure 3C The wall portion of the protective sleeve 300C is schematically shown, wherein a slit 320C with a width of approximately 10 µm is formed in a first layer 310C having a thickness of 10 µm. A second layer 330C having a thickness of approximately 1 µm is applied over the first layer, covering the slit to form a groove, a notch, and a breakable scoring line.
[0204] Figure 4 This is a cross-sectional view of a protective sleeve 400 according to another embodiment, which is manufactured by forming axial slits and overlapping walls to create a breakable scoring line. Slits 410 are cut from the distal end toward the proximal end in the walls of a polymer material layer (such as parylene C). Opposite wall segments are arranged radially to form overlapping wall segments. The overlapping wall segment 410 is covered by a second layer of parylene C or by a water-insoluble adhesive to form the breakable scoring line.
[0205] Figure 5 This is a cross-sectional view of an schematic component 500 according to the invention. The component has a protective sleeve having a first layer 510 with a through slit 520 covered by a second layer 530, the second layer 530 providing grooves or recesses forming a fractured scoring line that fractures axially from a distal to a proximal portion. Here, the second layer is only partially applied to the first layer. Inside the protective sleeve, an elongated device 540, schematically shown, is both water-sensitive and includes sharp edges and a rough surface. The component may be further coated with a friction-reducing material, such as gelatin, glycoprotein, or carbohydrate, to facilitate tissue insertion.
[0206] Figure 6a , Figure 6b , Figure 6c and Figure 6cAn assembly for introducing a live cell suspension is shown. The assembly (600) includes a sleeve (610) that houses a hollow cylindrical member (620) having a distal rectangular notch (621). The sleeve has a triangular notch (612) at its proximal end. A fine drawwire (613) is also attached to the proximal end of the sleeve. Furthermore, lateral notches (611) are axially arranged from the distal end in the proximal direction and are associated with the distal apex of the triangular notch. The sleeve further has three notches (partially obscured) extending around the distal end region, forming six distal end notches. Figure 6e An axial view along the proximal direction is shown from a position at the distal end of the cannula. Six dashed lines represent three notches extending around the distal end and the distal end region. After the assembly (600) is positioned within the soft tissue (640), the catheter (630) is inserted into the hollow member (620), and the live cell suspension (650) is placed within the distal volume of the cannula, the distal end of the cannula is broken along the notches extending around the distal end region by pulling a pull cord primarily in the axial direction. A notch (611) extends on one side of the cannula, engaging the distal apex of the rectangular notch (612) at the proximal end of the cannula. Figure 6a An assembly (600) is shown in which a sleeve (610) accommodates a hollow cylindrical member (620) positioned within soft tissue (640). Figure 6b A catheter (630) is shown inserted into a hollow member (620). A live cell suspension (650) is dispensed within the catheter (630) to the distal segment of the cannula, while also filling the gap between the hollow member (620) and the cannula (610), as shown. Figure 6c As shown. Figure 6d The illustration shows that after the cannula ruptures along the score line at the distal end (614), the live cell suspension (650) is absorbed by the soft tissue (640). The pull wire (613) is pulled in the proximal direction, and this pull contains a radial force vector, thereby causing the cannula to gradually rupture along the lateral score line as it is removed from the soft tissue. Example of a manufacturing apparatus
[0207] A solid, smooth stainless steel cylindrical pin, extending 10 cm from proximal to distal end, is used as a mold to manufacture the protective sleeve for the elongated device of the present invention. The pin is generally cylindrical with a 2 mm circular cross-section, and the distal section narrows radially toward its distal end, with a protrusion at its proximal end. The protrusion in the proximal portion of the pin serves as a mold for the flange of the protective sleeve. A 10 µm thick non-aqueous degradable polymer layer is then formed on the outer surface of the pin by vapor deposition of parylene C. Intersecting through slits are then formed in the distal portion using a suitable sharp tool, and slits extending toward the proximal end are formed (see [link to documentation]). Figure 2B Then, a second outer layer of non-aqueous degradable material is formed by applying a layer of parylene C approximately 1 µm thick using vapor deposition to cover these intersecting slits (see [link to article]). Figure 3A Then remove the protective sleeve with the fractured scoring lines thus formed from the pin, and then the medical object and the elongated device can be inserted into the protective sleeve.
[0208] The above process was repeated by applying a non-aqueous degradable polymer layer of parylene C with a thickness of approximately 10 µm onto the pin using vapor deposition. Figure 2A and Figure 2B As shown, intersecting through slits are formed in the distal portion using a suitable sharp tool, and intersecting through slits are also formed extending towards the proximal end. In a first alternative, a second outer layer of non-aqueous degradable material is formed by applying a layer of parylene C approximately 1 µm thick using vapor deposition to cover the slits; see [link to relevant documentation]. Figure 3C This forms a groove or recess. In a second alternative, the opposing wall portions of the groove are arranged to form an overlapping portion, see [reference needed]. Figure 4 The weak points of this structure were coated with a 1 µm thick layer of parylene C by vapor deposition.
[0209] Finally, during the above process, the protective sleeve is removed from the pin, and a slender medical device can be introduced into the protective sleeve. During this process, the second layer can be applied after the pin is removed and the slender device is inserted.
[0210] In the aforementioned manufacturing process, the pin's external shape may at least partially have a circular, elliptical, rectangular, or rhomboid cross-section, and have a distal segment that tapers radially toward its distal end, suitable for forming an elongated protective sleeve. The pin's surface is preferably smooth to facilitate subsequent processes. The pin may be hollow or solid, and is made, for example, of polymers, stainless steel, tungsten, glass, crystals, or ceramics. Furthermore, when appropriate during manufacturing, the pin may be coated with a soluble agent, such as gelatin or carbohydrates, to support subsequent processes.
[0211] The pin may be provided with one or more defined radially projecting portions that serve as a mold for one or more radially extending proximal flanges of the protective sleeve, which are continuously formed when at least one layer (preferably a first, thicker layer) of the protective sleeve is applied. During manufacturing, wire of sufficient strength may be attached to these flanges to facilitate subsequent operations of the protective sleeve. Other embodiments of the invention
[0212] 1. A component configured for inserting a medical object requiring protection into soft tissue, such as nerve tissue, the component comprising a cannula housing an elongated device including at least one element imparting rigidity, the elongated device having an overall diameter of less than about 5 mm, preferably less than 2 mm, the cannula having a proximal segment and a distal segment and a distal end, the proximal segment extending from the proximal end in a proximal-to-distal direction, the distal segment extending from the distal end in a proximal-to-distal direction, the diameter of the distal segment gradually decreasing toward the distal end (i.e., in the distal end region), the cannula including a cannula wall comprising a water-resistant polymer material, the cannula wall having a diameter of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm. The cannula has an average thickness of µm and further includes at least one draw wire integrated or attached to the proximal segment of the cannula, wherein the cannula (or cannula wall) includes a weak portion at least in the distal segment, which allows the distal segment to rupture (break) when an axial force is applied to the distal segment, such as the distal end region or the distal end, by an elongated medical device.
[0213] 2. The assembly of claim 1, wherein the axial force applied to the distal segment of the sleeve, particularly the distal end region, such as the distal end, is provided by moving at least the distal segment of the sleeve in a proximal direction by applying a basic axial force to the at least one pull wire.
[0214] 3. The component according to claim 1 or 2, wherein the weak part of the structure is a scoring area / fractured area / tearable area, such as a scoring area.
[0215] 4. The component according to any one of the preceding claims, wherein the weak point is a scoring line / breakable line / tear line, such as a scoring line.
[0216] 5. The component of claim 3, wherein the notched area / fractured area / tearable area is selected from reduced or overlapping wall segments of the average thickness of the polymer material.
[0217] 6. The component according to claim 3, wherein the longitudinal notch / fractured area / tear area is a reduction in the average thickness of the polymer material, wherein (preferably longitudinal) the width of the notch / fractured area / tear area is less than 500 µm, less than 400 µm, less than 300 µm, less than 200 µm, less than 100 µm, less than 50 µm, less than 10 µm, or less than 5 µm.
[0218] 7. The component according to claim 5, wherein the thickness of the scoring area / fractured area / tear area is less than 80%, 70%, 60%, 50%, 40%, 30%, 20%, 10%, 5%, 1%, 0.5%, or 0.1% of the average thickness of the sleeve wall.
[0219] 8. The component according to any one of the preceding claims, wherein the sleeve material is waterproof, preferably insoluble in water.
[0220] 9. The component according to any one of the preceding claims, wherein the sleeve is waterproof, preferably insoluble in water.
[0221] 10. The component according to any one of the preceding claims, wherein the sleeve wall comprises at least two layers, preferably two layers, of a polymeric water-resistant material.
[0222] 11. The component according to claim 3, wherein the longitudinal scoring area / fractured area / tear area has an aspect ratio of at least 10, preferably at least 100, preferably at least 1000, preferably at least 10000.
[0223] 12. The component of claim 3, wherein the longitudinal scoring area / fractured area / tear area is continuous or discontinuous.
[0224] 13. The component according to any one of the preceding claims, wherein the axial force applied to the distal segment, such as the distal end region, the distal end, is achieved by moving at least the distal segment of the sleeve in the proximal direction by pulling at least one cable in the direction having the axial force vector.
[0225] 14. The component of claim 4, wherein at least one serration is arranged in the distal segment of the protective sleeve.
[0226] 15. The component of claim 4, wherein at least one notch line extends around the distal portion of the distal segment.
[0227] 16. The component according to claim 14 or 15, wherein at least one notch extends from the distal segment in the proximal direction, preferably on one or both sides of the sleeve.
[0228] 17. The component according to any one of claims 4, 14-16, wherein at least one notch line substantially bisects the distal end region.
[0229] 18. The component according to any one of claims 4, 14-17, wherein the sleeve includes at least two scoring lines that extend around the distal end region and intersect each other in the distal end region.
[0230] 19. The component of claim 18, wherein at least two notch lines are arranged substantially uniformly around the circumference at any axial location in the distal end region.
[0231] 20. The component according to claim 18 or 19, wherein at least two score lines are arranged at approximately equal angular intervals around the sleeve axis (spaced apart) (when viewed axially in the proximal direction).
[0232] 21. The component according to any one of claims 18-20, wherein all the scribe lines intersect each other in a very restricted area, preferably characterized as a point (or intersecting region / intersection).
[0233] 22. The component of claim 21, wherein the intersection point coincides with the farthest tip of the distal end.
[0234] 23. The component according to any one of claims 18-22, wherein, when viewed from the distal end position in the proximal direction, the number of score lines around the sleeve axis (referred to as distal end score lines) follows the following equation for at least two score lines: the number N of score lines extending around the distal end region is equal to the number N+N of score lines around the sleeve axis when viewed from the distal end position in the proximal direction.
[0235] 24. The component of claim 23, wherein the angle between the two distal end notches preferably varies by a maximum of 10° and a maximum of 5°.
[0236] 25. The component according to any one of the preceding claims, wherein the sleeve includes at least one notch at its proximal end.
[0237] 26. The component of claim 25, wherein the notch has a triangular geometry and is preferably oriented such that one of its edges (or vertices) points toward a distal direction, which is preferably aligned substantially along the longitudinal axis of the sleeve.
[0238] 27. The component according to any one of claims 14-26, wherein at least one scoring line extends to the proximal end of the sleeve.
[0239] 28. The component of claim 26, wherein at least one serration extends to the edge of the triangular notch.
[0240] 29. The component according to any one of claims 18-28, wherein the sleeve includes at least three score lines extending around a distal end region and intersecting each other in the distal end region, and a score line extending towards the proximal end of the sleeve.
[0241] 30. The component of claim 29, wherein the sleeve includes two notches, preferably only one, in the proximal end of the sleeve, the notch having a triangular geometry and preferably oriented such that one of its edges (or vertices) points toward a distal direction, the distal direction preferably being substantially aligned along the longitudinal axis of the sleeve, and the notch extending along the proximal direction extending to the edge of the triangular notch.
[0242] 31. The component according to any one of the preceding claims, wherein the distal end region tapers in the distal direction and becomes pointed at the distal end, the distal end of which is aligned with the central axis, and preferably has a sharp tip.
[0243] 32. The component of claim 31, wherein the taper is conical or parabolic.
[0244] 33. The component according to any one of the preceding claims, wherein the distal end region is configured with longitudinal ridges and / or grooves evenly distributed along the circumference, preferably configured with any number of ridges and grooves evenly distributed along the circumference, such as at least three or at least four ridges and / or grooves evenly distributed along the circumference.
[0245] 34. The component according to any one of the preceding claims, wherein the elongated medical device comprises one or more of, or selected from, hollow elongated medical devices such as cannulas, needles, catheters, electrodes, light guides, guide tubes, sheaths, and rigid elongated elements.
[0246] 34. The component according to any one of the preceding claims, wherein the elongated medical device structural element comprises at least one flexible microelectrode.
[0247] 35. The component according to any one of the preceding claims, wherein the elongated medical device is a flexible microelectrode comprising at least one proximal-insulated conductive core.
[0248] 36. The component according to any one of the preceding claims, wherein the elongated medical device is a flexible microelectrode comprising at least one proximal insulated conductive core, and further comprising a water-soluble and / or water-degradable material that is substantially rigid when dry.
[0249] 37. The component of claim 36, wherein the flexible microelectrode is embedded in a water-soluble and / or water-degradable material.
[0250] 38. A method for inserting an elongated medical device comprising at least one elongated rigid structural element into soft tissue, such as nerve tissue, the elongated medical device having an overall diameter of less than about 5 mm, preferably less than 1 mm, the method comprising receiving at least a portion of the elongated medical device in a water-resistant sleeve to provide an assembly for inserting a medical object requiring protection, the sleeve having a proximal segment and a distal segment and a distal end, the proximal segment extending from the proximal end in a distal direction, the distal segment extending from the distal end in a proximal direction, the diameter of the distal segment gradually decreasing toward the distal end, the sleeve including a sleeve wall comprising a water-resistant polymer material, the sleeve wall having a diameter of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm. The cannula has an average thickness of µm and further includes at least one draw wire integrated or attached to the proximal segment of the cannula, wherein the cannula (or cannula wall) includes a weak portion at least in the distal segment, which allows the distal segment to rupture when an axial force is applied to the distal segment by the elongated medical device.
[0251] 39. The method of claim 38, wherein the axial force applied to the distal segment of the sleeve is provided by moving at least the distal segment of the sleeve in a proximal direction by applying an axial force to the at least one pull wire.
[0252] 40. The method of claim 38 or 39, wherein the axial force is applied after the component is placed within the soft tissue.
[0253] 41. The method according to any one of claims 38-40, further comprising: surrounding at least a portion of the distal segment of the elongated object within a cannula to form an assembly; introducing the assembly into soft tissue; positioning the assembly within the soft tissue; rupturing or breaking at least a weak point of the cannula by applying an axial force, thereby allowing tissue fluid to enter and contact the medical object; removing the cannula from the soft tissue, or optionally removing the assembly.
[0254] 42. A method of manufacturing a component according to any one of claims 1-37, comprising:
[0255] Provide a removable pin or elongated medical device shaped to form a cannula, and optionally coat the pin or the elongated device with a solvent;
[0256] Apply a first layer of water-resistant polymer material to the pin or elongated device;
[0257] At least one structurally weak part (such as a slit or groove, e.g., a longitudinally scored area / fractured area / tear area / such as a score line) is formed in the first inner layer.
[0258] Optionally, a second layer of water-resistant polymer material is applied, the second layer covering at least structurally weak parts, such as grooves, and the first layer and the optional second layer provide the casing wall;
[0259] Alternatively, the pin can be removed and a slender medical device inserted into the cannula.
[0260] 43. The method of claim 42, wherein the thickness of the first inner layer is at least 2 times, at least 3 times, at least 4, 5, 6, 7, 8, 9, or 10 times the thickness of the second layer.
[0261] 44. The method according to claim 42 or 43, wherein the layer is made of parylene, such as parylene N, parylene C, parylene D, parylene HT / AF4, preferably parylene C.
[0262] 45. The method according to any one of claims 42-44, wherein the structural weakness is formed by cutting the first layer to form a slit, the width of which is preferably less than 5 µm, optionally by overlapping opposite wall portions to form an overlapping wall segment, and by applying a second layer covering at least the slit and / or the overlapping wall segment.
Claims
1. An assembly configured for inserting a medical object requiring protection into soft tissue, such as nerve tissue, the assembly comprising a water-resistant sheath housing an elongated device including at least one element imparting rigidity, the elongated device having an overall diameter of less than about 5 mm, preferably less than 2 mm, the sheath having a proximal segment and a distal segment and a distal end, the proximal segment extending from a proximal end toward a distal end, the distal segment extending from a distal end toward a proximal end, the diameter of the distal segment gradually decreasing toward the distal end, the sheath including a sheath wall comprising a water-resistant polymer material, the sheath wall having an average thickness of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm, the sheath further including at least one drawwire integrated or attached to the proximal segment of the sheath, wherein, The sleeve includes at least a weak portion in its distal segment, which allows the distal segment to fracture when an axial force is applied to the distal segment, such as the distal end region, by the elongated device.
2. The assembly of claim 1, wherein the axial force applied to the distal segment is provided by pulling at least one wire in a direction having an axial force vector, thereby moving at least the distal segment of the sleeve toward the proximal end.
3. The component according to claim 1 or 2, wherein the structural weak point is a scored area, such as a score line.
4. The component of claim 3, wherein the serration line is selected from a slit passing through the sleeve wall, a reduction in the average thickness of the polymer material, an overlapping wall segment, and a reduction in the average thickness of the polymer material.
5. The component of claim 3, wherein the groove is a groove (recess) with a reduced average thickness of the polymer material, wherein the width of the groove (recess) is less than 500 µm, less than 400 µm, less than 300 µm, less than 200 µm, less than 100 µm, less than 50 µm, less than 10 µm, or less than 5 µm.
6. The component according to claim 5, wherein the thickness of the scribe line is less than 80%, 70%, 60%, 50%, 40%, 30%, 20%, 10%, 5%, 1%, 0.5%, or 0.1% of the average thickness of the sleeve wall.
7. The component according to any one of the preceding claims, wherein the sleeve material is waterproof, preferably insoluble in water, and the sleeve is preferably waterproof, preferably insoluble in water.
8. The component according to any one of the preceding claims, wherein the sleeve wall comprises at least two layers, preferably two layers, of a polymeric water-resistant material.
9. The component of claim 3, wherein at least one serration is arranged in the distal segment of the protective sleeve.
10. The component of claim 3, wherein at least one notch line extends around the distal portion of the distal segment.
11. The component according to claim 9 or 10, wherein at least one serration extends from the distal segment toward the proximal segment, preferably on one side of the sleeve.
12. The component according to any one of claims 3, 9-11, wherein the at least one notch line substantially bisects the region of the distal end.
13. The component according to any one of claims 3, 9-12, wherein the sleeve includes at least two scoring lines that extend around a region of the distal end and intersect each other in the region of the distal end.
14. The component of claim 13, wherein the at least two notch lines are arranged substantially uniformly around the circumference at any axial location in the region of the distal end.
15. The component according to claim 13 or 14, wherein the at least two notch lines are arranged at approximately equal angular intervals (spaced apart) around the sleeve axis (when viewed axially in the proximal direction).
16. The component according to any one of claims 13-15, wherein all the scribe lines intersect each other in a very restricted area, preferably characterized as a point (or intersecting region / intersection), preferably said intersection coinciding with the farthest tip of said distal end.
17. The component according to any one of the preceding claims, wherein the sleeve includes at least one notch at its proximal end.
18. The component of claim 17, wherein the notch has a triangular geometry and is preferably oriented such that one of its edges (or vertices) points toward a distal direction, the distal direction preferably being substantially aligned along the longitudinal axis of the sleeve.
19. The component according to any one of claims 9-18, wherein at least one scoring line extends to the proximal end of the sleeve.
20. The component of claim 18, wherein at least one notch line extends to the edge of the triangular notch.
21. The component according to any one of claims 9-20, wherein the sleeve includes at least three score lines extending around a region of the distal end and intersecting each other in the region of the distal end, and a score line extending towards the proximal end of the sleeve.
22. The component of claim 21, wherein the sleeve includes a notch located at the proximal end of the sleeve, the notch having a triangular geometry and preferably oriented such that one of its edges (or vertices) points toward a distal direction, the distal direction preferably being substantially aligned with the longitudinal axis of the sleeve, wherein a notch extending along the proximal direction extends to the distal edge of the triangular notch.
23. The component according to any one of the preceding claims, wherein the distal end region tapers along the distal direction and has a pointed distal end, the distal end having the pointed distal end being aligned with the central axis and preferably having a sharp tip, the taper preferably being conical or parabolic.
24. The component according to any one of the preceding claims, wherein the region of the distal end segment with a diameter decreasing toward the distal end is provided with longitudinal ridges and / or grooves uniformly distributed along the circumference, preferably provided with any number of ridges and grooves uniformly distributed along the circumference, such as at least three or at least four ridges and / or grooves uniformly distributed along the circumference.
25. The component according to any one of the preceding claims, wherein the elongated device comprises one or more of the following: hollow elongated medical devices, such as cannulas, needles, catheters, electrodes, light guides, guide tubes, sheaths, and rigid elongated elements.
26. The component according to any one of the preceding claims, wherein the elongated device is a flexible microelectrode comprising at least one proximal-insulated conductive core, and further comprising a water-soluble and / or water-degradable material, said material being substantially rigid when dry, preferably the flexible microelectrode being embedded in said water-soluble and / or water-degradable material.
27. The component according to claim 1, wherein the axial force is less than 5 N, preferably less than 2 N, less than 1 N, or less than 0.5 N.
28. The component according to any one of the preceding claims, wherein the elongated device is a hollow member serving as an element imparting rigidity, the hollow member being configured to accommodate a conduit.
29. The component according to any one of the preceding claims, wherein the medical object is selected from medical devices that can monitor and / or stimulate soft tissue by, for example, electrical, thermal, ultrasonic, optogenetic, or mechanical monitoring and / or stimulation; and compounds, peptides, proteins, biological macromolecules, and microorganisms, such as pharmaceuticals, peptides, proteins, genes, living cells, and aggregates of living cells.
30. A method of inserting an elongated device comprising at least one rigid element into soft tissue, such as nerve tissue, the elongated device having an overall diameter of less than about 5 mm, preferably less than 2 mm, the method comprising receiving at least a portion of the elongated device in a water-resistant sleeve to provide an assembly configured for insertion into a medical object requiring protection, the water-resistant sleeve having a proximal section and a distal section and a distal end, the proximal section extending from the proximal end in a proximal-to-distal direction, the distal section extending from the distal end in a proximal-to-distal direction, the diameter of the distal section gradually decreasing toward the distal end, the sleeve comprising a sleeve wall comprising a water-resistant polymer material, the sleeve wall having a diameter of less than 100 µm, preferably less than 50 µm, for example from 0.2 µm to 50 µm. The sleeve has an average thickness of µm and further includes at least one draw wire integrated or attached to the proximal segment of the sleeve, wherein the sleeve (or sleeve wall) includes a weak portion at least in the distal segment, which allows the distal segment to fracture when the elongated device applies an axial force to the distal segment.
31. The method of claim 30, wherein the axial force applied to the distal segment of the sleeve is provided by applying an axial force on at least one pull wire to move at least the distal segment of the sleeve in a proximal direction.
32. The method of claim 30 or 31, wherein the axial force is applied after the component is placed within the soft tissue.
33. The method according to any one of claims 30-32, wherein the axial force is less than 5 N, preferably less than 2 N, such as less than 1 N or less than 0.6 N.
34. The method according to any one of claims 30-33, further comprising: Enclosing at least a portion of the distal segment of an elongated object within the sleeve, thereby forming an assembly; Introduce the component into soft tissue; Position the component within soft tissue; rupture or break at least one weak point of the cannula by applying the axial force, thereby allowing tissue fluid to enter and contact the medical object; remove the cannula from the soft tissue, or optionally remove the component.
35. A method of manufacturing a component according to any one of claims 1-29, comprising: A removable pin shaped to form a sleeve is provided, or an elongated device is provided, and the pin or the elongated device may optionally be coated with a solvent. A first layer of water-resistant polymer material is applied to the pin or elongated device; At least one structurally weak part (such as a slit or groove, e.g., a longitudinally scored area / fractured area / tear area / such as a score line) is formed in the first inner layer. Optionally, a second layer of water-resistant polymer material is applied, the second layer covering at least the structural weak points, such as grooves, and the first layer and the optional second layer provide the sleeve wall; Alternatively, the pin can be removed and the elongated device inserted into the sleeve.
36. The method of claim 35, wherein the thickness of the first inner layer is at least 2 times, at least 3 times, at least 4 times, 5 times, 6 times, 7 times, 8 times, 9 times, or 10 times the thickness of the second layer.
37. The method according to claim 35 or 36, wherein the layer is made of parylene, such as parylene N, parylene C, parylene D, parylene HT / AF4, preferably parylene C.
38. The method according to any one of claims 35-37, wherein the structural weak portion is formed by cutting the first layer to form a slit, the width of the slit preferably being less than 5 µm, optionally overlapping opposite wall portions to form an overlapping wall segment, and applying a second layer covering at least the slit and / or the overlapping wall segment.
Citation Information
Patent Citations
Electrode array
WO2008091197A1
Method of implantation of a medical device into neural tissue
WO2016032384A1
Device for insertion into nervous tissue
WO2018217147A1
Method of microelectrode identification
WO2018222101A1
Spontaneous alignment aid for liquid crystal composition
WO2019003936A1
